Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:7,12-dimethyltetraphene
go back to main search page
Accession:CHEBI:254496 term browser browse the term
Definition:A tetraphene having methyl substituents at the 7- and 12-positions. It is a potent carcinogen and is present in tobacco smoke.
Synonyms:related_synonym: 1,4-Dimethyl-2,3-benzphenanthrene;   6,7-Dimethyl-1,2-benzanthracene;   7,12-DMBA;   7,12-Dimethyl-1,2-benzanthracene;   7,12-Dimethyl-1:2-benz(a)anthracene;   7,12-Dimethylbenz(a)anthracene;   7,12-Dimethylbenzanthracene;   7,12-Dimethylbenzanthrancene;   7,12-dimethylbenzo[a]anthracene;   9,10-Dimethyl-1,2-benzanthracene;   9,10-Dimethyl-1,2-benzanthrazen;   9,10-Dimethylbenz(a)anthracene;   DMBA;   Formula=C20H16;   InChI=1S/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3;   InChIKey=ARSRBNBHOADGJU-UHFFFAOYSA-N;   SMILES=Cc1c2ccccc2c(C)c2c1ccc1ccccc21
 alt_id: CHEBI:59032
 xref: Beilstein:1912135;   CAS:57-97-6;   Gmelin:263937;   KEGG:C19488;   LINCS:LSM-37159
 xref_mesh: MESH:D015127
 xref: PMID:11488430;   PMID:12839762;   PMID:16020197;   PMID:18992763;   PMID:7561049


show annotations for term's descendants           Sort by:
 
7,12-dimethyltetraphene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ABCB1B mRNA CTD PMID:32553695 NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 affects response to substance ISO ABCC6 gene SNP affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:25622337 NCBI chr 1:101,954,786...102,013,252
Ensembl chr 1:101,959,540...102,013,243
JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ABHD3 mRNA CTD PMID:21527772 NCBI chr18:1,892,413...1,946,840
Ensembl chr18:1,892,413...1,946,840
JBrowse link
G Acad8 acyl-CoA dehydrogenase family, member 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ACAD8 mRNA CTD PMID:32553695 NCBI chr 8:28,023,401...28,044,967
Ensembl chr 8:28,024,123...28,044,876
JBrowse link
G Actb actin, beta affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ACTB mRNA CTD PMID:21785161 NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
JBrowse link
G Actg2 actin gamma 2, smooth muscle increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTG2 mRNA CTD PMID:19480007 NCBI chr 4:115,215,160...115,239,746
Ensembl chr 4:115,215,060...115,239,723
JBrowse link
G Actn1 actinin, alpha 1 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ACTN1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTN1 protein
CTD PMID:22248470 NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
JBrowse link
G Actn3 actinin alpha 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACTN3 mRNA CTD PMID:19480007 NCBI chr 1:220,120,532...220,136,460
Ensembl chr 1:220,120,533...220,136,470
JBrowse link
G Actn4 actinin alpha 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTN4 mRNA CTD PMID:12376462 NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
JBrowse link
G Actr3b actin related protein 3B increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTR3B mRNA CTD PMID:19480007 NCBI chr 4:5,644,287...5,672,708
Ensembl chr 4:5,644,260...5,672,708
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ADAMTS1 mRNA CTD PMID:32553695 NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ADAMTS9 mRNA CTD PMID:32553695 NCBI chr 4:124,660,254...124,860,997
Ensembl chr 4:124,660,262...124,858,250
JBrowse link
G Adcy5 adenylate cyclase 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ADCY5 mRNA CTD PMID:12376462 NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ADGRL4 mRNA CTD PMID:19480007 NCBI chr 2:256,609,787...256,724,642
Ensembl chr 2:256,609,787...256,724,641
JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ADH7 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ADH7 mRNA
CTD PMID:32553695 NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
JBrowse link
G Adm adrenomedullin increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ADM mRNA CTD PMID:19480007 NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
JBrowse link
G Adss adenylosuccinate synthase affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ADSS mRNA CTD PMID:21785161 NCBI chr13:95,913,426...95,943,761
Ensembl chr13:95,913,426...95,943,761
JBrowse link
G Aen apoptosis enhancing nuclease increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AEN mRNA CTD PMID:32553695 NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
JBrowse link
G Ago2 argonaute RISC catalytic component 2 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]
CTD PMID:24792773 NCBI chr 7:114,339,607...114,377,277
Ensembl chr 7:114,339,434...114,380,613
JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of AHCYL1 mRNA CTD PMID:21785161 NCBI chr 2:210,438,884...210,474,350
Ensembl chr 2:210,438,893...210,473,761
JBrowse link
G Ahr aryl hydrocarbon receptor increases activity
multiple interactions
affects localization
affects binding
increases expression
affects response to substance
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of AHR protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ADH7 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of AHRR mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ALDH3A1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of BTG2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNG1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNO mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CXCL5 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DDIT4 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DOK1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of FOSL1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GCHFR mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of INHBB mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of LPL mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NQO1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PGD mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTGS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTX3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SPP1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA; [AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which results in decreased expression of CYP1A1; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARTN protein]; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL4RA]; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP]; galangin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
9,10-Dimethyl-1,2-benzanthracene binds to AHR protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR protein
AHR affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene; AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of AHR protein; AHR protein promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]
CTD PMID:3024361, PMID:9855628, PMID:10953044, PMID:12117779, PMID:12200463, PMID:12559965, PMID:14678569, PMID:15667830, PMID:16903077, PMID:17275817, PMID:18205319, PMID:20562217, PMID:22406437, PMID:25110319, PMID:27869817, PMID:32553695 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of AHRR mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of AHRR mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AHRR mRNA
CTD PMID:27891153, PMID:32553695 NCBI chr 1:31,603,297...31,698,329
Ensembl chr 1:31,603,297...31,698,329
JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKR1B10 mRNA CTD PMID:26198647 NCBI chr 4:61,813,265...61,830,371
Ensembl chr 4:61,771,970...61,828,657
JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 multiple interactions ISO AKR7A2 protein results in increased reduction of and affects the activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:21910479 NCBI chr 5:157,759,448...157,768,473
Ensembl chr 5:157,759,416...157,768,471
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases expression
increases phosphorylation
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKT1 protein modified form
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKT1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of AKT1 protein
CTD PMID:21785161, PMID:24576726 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Alas2 5'-aminolevulinate synthase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALAS2 mRNA CTD PMID:19480007 NCBI chr  X:23,167,576...23,187,356
Ensembl chr  X:23,167,696...23,187,341
JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ALDH3A1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ALDH3A1 mRNA
CTD PMID:32553695 NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALDOA protein CTD PMID:22248470 NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANAPC5 mRNA CTD PMID:21785161 NCBI chr12:39,209,134...39,242,696
Ensembl chr12:39,209,129...39,242,690
JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions
increases methylation
EXP [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of ANGPTL4 promoter] which results in decreased expression of ANGPTL4 mRNA CTD PMID:21489049 NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
JBrowse link
G Ankh ANKH inorganic pyrophosphate transport regulator increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANK mRNA CTD PMID:19480007 NCBI chr 2:80,131,563...80,256,948
Ensembl chr 2:80,131,563...80,256,954
JBrowse link
G Anxa1 annexin A1 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 protein
CTD PMID:12376462, PMID:22248470 NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
JBrowse link
G Anxa2 annexin A2 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA2 protein CTD PMID:22248470 NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
JBrowse link
G Anxa8 annexin A8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ANXA8 mRNA CTD PMID:32553695 NCBI chr16:10,417,174...10,432,388
Ensembl chr16:10,417,185...10,432,393
JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions
decreases expression
ISO [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein
CTD PMID:18791811, PMID:25478867 NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions
increases expression
ISO Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of APEX1 mRNA] CTD PMID:25697376 NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of APOBEC1 mRNA CTD PMID:32553695 NCBI chr 4:155,386,367...155,414,034
Ensembl chr 4:155,386,711...155,401,480
JBrowse link
G Apoc1 apolipoprotein C1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of APOC1 mRNA CTD PMID:21785161 NCBI chr 1:80,606,638...80,609,921
Ensembl chr 1:80,606,638...80,609,921
JBrowse link
G Apoe apolipoprotein E affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of APOE mRNA CTD PMID:21785161 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
JBrowse link
G Aqp1 aquaporin 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP1 mRNA CTD PMID:12376462 NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AQP3 mRNA CTD PMID:19480007 NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
JBrowse link
G Aqp5 aquaporin 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP5 mRNA CTD PMID:19480007 NCBI chr 7:141,249,044...141,252,576
Ensembl chr 7:141,249,044...141,252,578
JBrowse link
G Ar androgen receptor multiple interactions
increases activity
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene binds to and results in decreased activity of AR protein; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Metribolone results in increased activity of AR protein]
9,10-Dimethyl-1,2-benzanthracene results in increased activity of AR protein
CTD PMID:10771140, PMID:18324785 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arhgap11a Rho GTPase activating protein 11A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARHGAP11A mRNA CTD PMID:32553695 NCBI chr 3:105,281,827...105,298,108
Ensembl chr 3:105,281,827...105,298,108
JBrowse link
G Arhgap6 Rho GTPase activating protein 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ARHGAP6 mRNA CTD PMID:32553695 NCBI chr  X:26,314,561...26,845,242
Ensembl chr  X:26,315,878...26,376,467
JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARHGDIB mRNA CTD PMID:21527772 NCBI chr 4:170,913,920...170,932,789
Ensembl chr 4:170,913,923...170,932,618
JBrowse link
G Arl16 ADP-ribosylation factor like GTPase 16 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ARL16 mRNA CTD PMID:21785161 NCBI chr10:109,636,770...109,639,018
Ensembl chr10:109,636,896...109,639,054
JBrowse link
G Arl6ip5 ADP-ribosylation factor like GTPase 6 interacting protein 5 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARL6IP5 mRNA
CTD PMID:32553695 NCBI chr 4:129,574,363...129,598,240
Ensembl chr 4:129,574,264...129,598,915
JBrowse link
G Arrdc3 arrestin domain containing 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARRDC3 mRNA CTD PMID:32553695 NCBI chr 2:8,732,907...8,745,445
Ensembl chr 2:8,732,932...8,743,069
JBrowse link
G Artn artemin multiple interactions
increases expression
ISO AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARTN protein] CTD PMID:27869817 NCBI chr 5:136,759,717...136,765,036
Ensembl chr 5:136,759,717...136,762,986
JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ASAH1 mRNA CTD PMID:21785161 NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
JBrowse link
G Asip agouti signaling protein multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene affects the reaction [A gene mutant form results in decreased expression of GJA4 protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of ATM mRNA]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of BRCA1 protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of PRKDC mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]; [A gene mutant form co-treated with 9,10-Dimethyl-1,2-benzanthracene] affects the expression of GJA4 protein; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein]; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 protein] CTD PMID:25447408, PMID:25448685 NCBI chr 3:150,492,010...150,579,870
Ensembl chr 3:150,574,473...150,579,870
JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ASS1 mRNA CTD PMID:32553695 NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ATAD2 mRNA CTD PMID:32553695 NCBI chr 7:97,984,754...98,027,379
Ensembl chr 7:97,984,862...98,026,052
JBrowse link
G Atg10 autophagy related 10 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ATG10 mRNA CTD PMID:32553695 NCBI chr 2:19,853,546...20,152,918
Ensembl chr 2:19,853,546...20,152,884
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased phosphorylation of ATM protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATM protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ATM mRNA
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of ATM mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATM mRNA
CTD PMID:23969067, PMID:25448685 NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5F1A protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ATP5F1A protein
CTD PMID:22248470 NCBI chr18:74,156,553...74,164,490
Ensembl chr18:74,156,553...74,164,495
JBrowse link
G Atp5f1b ATP synthase F1 subunit beta multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ATP5F1B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5F1B protein
CTD PMID:22248470 NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATPIF1 mRNA CTD PMID:12376462 NCBI chr 5:150,719,570...150,723,287
Ensembl chr 5:150,719,569...150,723,321
JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ATP6AP2 mRNA CTD PMID:21785161 NCBI chr  X:11,137,889...11,164,854
Ensembl chr  X:11,136,939...11,164,915
JBrowse link
G Atrnl1 attractin like 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ATRNL1 mRNA CTD PMID:32553695 NCBI chr 1:278,546,113...279,098,977
Ensembl chr 1:278,557,792...278,815,473
JBrowse link
G Axl Axl receptor tyrosine kinase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AXL mRNA CTD PMID:21527772 NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BASP1 mRNA CTD PMID:12376462 NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BAX mRNA
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BAX protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BAX protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA]
CTD PMID:18791811, PMID:20562217, PMID:22760862, PMID:24269759, PMID:25478867, PMID:30101532, PMID:32662567 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bbc3 Bcl-2 binding component 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BBC3 mRNA CTD PMID:32553695 NCBI chr 1:78,261,491...78,267,802 JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of BBS9 mRNA CTD PMID:32553695 NCBI chr 8:23,491,929...24,074,524
Ensembl chr 8:23,492,621...24,074,536
Ensembl chr 8:23,492,621...24,074,536
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Plant Extracts co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein
CTD PMID:18791811, PMID:20103723, PMID:20537511, PMID:22760862, PMID:25478867, PMID:30101532, PMID:32662567 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BCL6 mRNA CTD PMID:32553695 NCBI chr11:80,255,790...80,279,075
Ensembl chr11:80,255,790...80,279,075
JBrowse link
G Bdnf brain-derived neurotrophic factor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BDNF mRNA CTD PMID:32553695 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Becn1 beclin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BECN1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BECN1 protein CTD PMID:24576726 NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 protein
resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 protein]
CTD PMID:18791811 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
JBrowse link
G Bmi1 BMI1 proto-oncogene, polycomb ring finger increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]
CTD PMID:24792773 NCBI chr17:85,360,439...85,370,283
Ensembl chr17:85,364,483...85,368,208
JBrowse link
G Brat1 BRCA1-associated ATM activator 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of BRAT1 mRNA CTD PMID:21785161 NCBI chr12:16,016,062...16,028,534
Ensembl chr12:16,015,771...16,027,881
JBrowse link
G Brca1 BRCA1, DNA repair associated affects response to substance
increases expression
multiple interactions
ISO
EXP
BRCA1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of BRCA1 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 mRNA
CTD PMID:21507987, PMID:23969067, PMID:25448685 NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BSCL2 mRNA CTD PMID:22003191 NCBI chr 1:225,035,956...225,046,137
Ensembl chr 1:225,037,737...225,046,040
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BTG2 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of BTG2 mRNA
CTD PMID:32553695 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
JBrowse link
G C1qb complement C1q B chain affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QB mRNA CTD PMID:21785161 NCBI chr 5:155,246,444...155,251,995
Ensembl chr 5:155,246,447...155,252,003
JBrowse link
G C1qc complement C1q C chain affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QC mRNA CTD PMID:21785161 NCBI chr 5:155,255,013...155,258,631
Ensembl chr 5:155,255,005...155,258,392
JBrowse link
G C1s complement C1s affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1S mRNA CTD PMID:21785161 NCBI chr 4:157,143,592...157,155,592
Ensembl chr 4:157,143,592...157,155,609
JBrowse link
G C3 complement C3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of C3 mRNA CTD PMID:19480007 NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
JBrowse link
G Ca3 carbonic anhydrase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CAR3 protein CTD PMID:20045496 NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
JBrowse link
G Calr calreticulin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CALR mRNA CTD PMID:21785161 NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of CAPZA2 protein CTD PMID:22248470 NCBI chr 4:44,936,290...44,972,270
Ensembl chr 4:44,936,290...44,972,267
JBrowse link
G Car2 carbonic anhydrase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CAR2 mRNA CTD PMID:19480007 NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
JBrowse link
G Cask calcium/calmodulin dependent serine protein kinase increases expression
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASK mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CASK mRNA
CTD PMID:12376462, PMID:32553695 NCBI chr  X:9,815,652...10,156,155
Ensembl chr  X:9,815,652...10,156,155
JBrowse link
G Casp2 caspase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASP2 protein CTD PMID:21785161 NCBI chr 4:71,652,358...71,670,228
Ensembl chr 4:71,652,354...71,670,239
JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression
decreases activity
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP3 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein]
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASP3 protein
CTD PMID:16517061, PMID:21785161, PMID:23969067, PMID:25478867, PMID:30101532, PMID:32662567 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp9 caspase 9 decreases activity
decreases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP9 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]
CTD PMID:25478867, PMID:30101532, PMID:32662567 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Cat catalase multiple interactions
decreases expression
decreases activity
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of CAT protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of CAT protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of CAT protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of CAT protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of CAT protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of CAT protein]; geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein
allyl isothiocyanate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]
CTD PMID:20691676, PMID:23033690, PMID:24995432, PMID:25744308, PMID:31476248, PMID:32662567 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Cbln2 cerebellin 2 precursor decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CBLN2 mRNA CTD PMID:19480007 NCBI chr18:83,775,568...83,783,841
Ensembl chr18:83,777,665...83,782,930
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCL2 mRNA CTD PMID:32553695 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
increases expression
EXP citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCL3 mRNA] CTD PMID:31926054 NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCL5 mRNA
CTD PMID:12200463, PMID:19480007 NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
JBrowse link
G Ccl6 chemokine (C-C motif) ligand 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CCL6 mRNA CTD PMID:19480007 NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782
JBrowse link
G Ccn2 cellular communication network factor 2 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCN2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CTGF mRNA
CTD PMID:19480007, PMID:32553695 NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
JBrowse link
G Ccn3 cellular communication network factor 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCN3 mRNA CTD PMID:19480007 NCBI chr 7:94,375,134...94,382,154
Ensembl chr 7:94,375,020...94,383,024
JBrowse link
G Ccnb1 cyclin B1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCNB1 protein CTD PMID:20025956 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein
CTD PMID:12097258, PMID:12376462, PMID:21785161, PMID:29663660, PMID:32662567 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccng1 cyclin G1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCNG1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNG1 mRNA
CTD PMID:32553695 NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
JBrowse link
G Ccno cyclin O increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCNO mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNO mRNA
CTD PMID:32553695 NCBI chr 2:44,857,043...44,860,317
Ensembl chr 2:44,857,213...44,860,315
JBrowse link
G Cd109 CD109 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD109 mRNA CTD PMID:32553695 NCBI chr 8:85,951,420...86,065,411
Ensembl chr 8:85,951,191...86,065,409
JBrowse link
G Cd14 CD14 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD14 mRNA CTD PMID:32553695 NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
JBrowse link
G Cd3d CD3d molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD3D mRNA CTD PMID:19480007 NCBI chr 8:49,282,502...49,287,095
Ensembl chr 8:49,282,460...49,287,110
JBrowse link
G Cd3g CD3g molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD3G mRNA CTD PMID:19480007 NCBI chr 8:49,274,553...49,280,943
Ensembl chr 8:49,274,960...49,280,901
JBrowse link
G Cd44 CD44 molecule (Indian blood group) increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD44 mRNA CTD PMID:32553695 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
JBrowse link
G Cd5 Cd5 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD5 mRNA CTD PMID:19480007 NCBI chr 1:226,770,912...226,791,861
Ensembl chr 1:226,770,744...226,791,879
JBrowse link
G Cd52 CD52 molecule decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CD52 mRNA CTD PMID:19480007 NCBI chr 5:152,322,910...152,324,469
Ensembl chr 5:152,322,916...152,324,469
JBrowse link
G Cd59 CD59 molecule multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein CTD PMID:19965957, PMID:20202993 NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
JBrowse link
G Cd6 Cd6 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD6 mRNA CTD PMID:19480007 NCBI chr 1:226,848,399...226,887,259
Ensembl chr 1:226,848,403...226,887,156
JBrowse link
G Cd74 CD74 molecule affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CD74 mRNA CTD PMID:21785161 NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
JBrowse link
G Cd80 Cd80 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD80 mRNA CTD PMID:32553695 NCBI chr11:64,815,201...64,855,293
Ensembl chr11:64,827,635...64,855,353
JBrowse link
G Cd93 CD93 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD93 mRNA CTD PMID:19480007 NCBI chr 3:142,778,798...142,783,774
Ensembl chr 3:142,778,770...142,783,774
JBrowse link
G Cdh1 cadherin 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH1 protein CTD PMID:29663660 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
JBrowse link
G Cdh13 cadherin 13 multiple interactions
decreases expression
EXP AHR protein promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA] CTD PMID:12559965, PMID:19480007 NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDK4 mRNA CTD PMID:12376462 NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
JBrowse link
G Cdkal1 CDK5 regulatory subunit associated protein 1-like 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CDKAL1 mRNA CTD PMID:32553695 NCBI chr17:36,451,031...37,157,882
Ensembl chr17:36,451,058...37,295,069
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [Plant Extracts co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein
CTD PMID:20043298, PMID:20103723, PMID:21527772, PMID:21785161, PMID:23717041, PMID:25478867, PMID:32553695 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases response to substance
multiple interactions
increases methylation
decreases expression
ISO CDKN2A gene polymorphism results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein
CTD PMID:11544531, PMID:24792773 NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN2B mRNA CTD PMID:19480007 NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 multiple interactions
increases expression
EXP zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CEACAM5 protein] CTD PMID:31476248 NCBI chr 1:81,643,809...81,650,085
Ensembl chr 1:81,643,816...81,650,094
JBrowse link
G Celf5 CUGBP, Elav-like family member 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CELF5 mRNA CTD PMID:32553695 NCBI chr 7:11,095,449...11,119,941
Ensembl chr 7:11,095,468...11,119,941
JBrowse link
G Cenpb centromere protein B multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA CTD PMID:32553695 NCBI chr 3:123,720,888...123,723,520
Ensembl chr 3:123,721,486...123,723,524
JBrowse link
G Cep112 centrosomal protein 112 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CEP112 mRNA CTD PMID:32553695 NCBI chr10:96,660,294...97,146,426
Ensembl chr10:96,663,740...97,146,424
JBrowse link
G Cercam cerebral endothelial cell adhesion molecule decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CERCAM mRNA CTD PMID:19480007 NCBI chr 3:8,421,116...8,444,743
Ensembl chr 3:8,430,829...8,444,851
JBrowse link
G Cfd complement factor D decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CFD mRNA CTD PMID:19480007 NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CGREF1 mRNA CTD PMID:32553695 NCBI chr 6:26,797,126...26,809,132
Ensembl chr 6:26,797,126...26,809,129
JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CHCHD6 mRNA CTD PMID:32553695 NCBI chr 4:121,340,952...121,565,222
Ensembl chr 4:121,340,952...121,565,212
JBrowse link
G Chek1 checkpoint kinase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CHEK1 protein CTD PMID:20025956 NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
JBrowse link
G Chi3l1 chitinase 3 like 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CHI3L1 mRNA CTD PMID:21785161 NCBI chr13:51,022,844...51,030,797
Ensembl chr13:51,022,681...51,030,802
JBrowse link
G Cidec cell death-inducing DFFA-like effector c decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CIDEC mRNA CTD PMID:19480007 NCBI chr 4:145,377,482...145,390,497
Ensembl chr 4:145,377,431...145,390,497
JBrowse link
G Ckap2 cytoskeleton associated protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CKAP2 mRNA CTD PMID:32553695 NCBI chr16:74,752,655...74,779,184
Ensembl chr16:74,752,655...74,779,184
JBrowse link
G Clca1 chloride channel accessory 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CLCA1 mRNA CTD PMID:19480007 NCBI chr 2:250,897,980...250,923,711
Ensembl chr 2:250,897,969...250,923,744
JBrowse link
G Cldn3 claudin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CLDN3 mRNA CTD PMID:12097258 NCBI chr12:21,831,341...21,832,813
Ensembl chr12:21,831,342...21,832,813
JBrowse link
G Clec10a C-type lectin domain containing 10A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CLEC10A mRNA CTD PMID:32553695 NCBI chr10:56,764,927...56,769,447
Ensembl chr10:56,764,927...56,769,457
JBrowse link
G Clstn3 calsyntenin 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CLSTN3 mRNA CTD PMID:32553695 NCBI chr 4:157,044,736...157,078,013
Ensembl chr 4:157,043,925...157,078,130
JBrowse link
G Cnn3 calponin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CNN3 mRNA CTD PMID:12376462 NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
JBrowse link
G Col1a2 collagen type I alpha 2 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL1A2 mRNA CTD PMID:19480007 NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
JBrowse link
G Col4a6 collagen type IV alpha 6 chain decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of COL4A6 mRNA CTD PMID:32553695 NCBI chr  X:112,405,647...112,768,337
Ensembl chr  X:112,405,647...112,473,822
JBrowse link
G Col5a1 collagen type V alpha 1 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A1 mRNA CTD PMID:12376462 NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A3 mRNA CTD PMID:19480007 NCBI chr 8:21,786,324...21,831,751
Ensembl chr 8:21,786,324...21,831,668
JBrowse link
G Colec10 collectin subfamily member 10 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of COLEC10 mRNA CTD PMID:32553695 NCBI chr 7:93,975,451...94,035,999
Ensembl chr 7:93,975,451...94,035,999
JBrowse link
G Coro1a coronin 1A increases methylation
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CORO1A promoter
[9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CORO1A promoter] which results in decreased expression of CORO1A mRNA
CTD PMID:21489049 NCBI chr 1:198,123,883...198,128,890
Ensembl chr 1:198,123,884...198,128,857
JBrowse link
G Cpa6 carboxypeptidase A6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CPA6 mRNA CTD PMID:32553695 NCBI chr 5:8,215,443...8,574,655
Ensembl chr 5:8,459,660...8,574,655
JBrowse link
G Cpb1 carboxypeptidase B1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CPB1 mRNA CTD PMID:32553695 NCBI chr 2:105,059,293...105,089,682
Ensembl chr 2:105,059,426...105,089,659
JBrowse link
G Cpox coproporphyrinogen oxidase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CPOX mRNA CTD PMID:32553695 NCBI chr11:44,039,665...44,049,648
Ensembl chr11:44,039,669...44,049,648
JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CRABP2 mRNA CTD PMID:21527772 NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CREB3L3 mRNA CTD PMID:27891153 NCBI chr 7:11,490,852...11,499,287
Ensembl chr 7:11,490,852...11,499,282
JBrowse link
G Csde1 cold shock domain containing E1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CSDE1 mRNA CTD PMID:21785161 NCBI chr 2:205,525,194...205,552,987
Ensembl chr 2:205,525,204...205,552,991
JBrowse link
G Csf1r colony stimulating factor 1 receptor multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Fluoxetine] affects the expression of CSF1R protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of CSF1R protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of CSF1R protein CTD PMID:31332895 NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
JBrowse link
G Csf2 colony stimulating factor 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA CTD PMID:14678569 NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
JBrowse link
G Csf3 colony stimulating factor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF3 mRNA CTD PMID:14678569 NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
JBrowse link
G Csn1s1 casein alpha s1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CSN1S1 mRNA CTD PMID:19480007 NCBI chr14:21,993,450...22,009,308
Ensembl chr14:21,993,427...22,009,308
JBrowse link
G Csn2 casein beta decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CSN2 protein CTD PMID:22248470 NCBI chr14:21,972,274...21,979,511
Ensembl chr14:21,972,274...21,979,510
JBrowse link
G Cth cystathionine gamma-lyase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CTH mRNA CTD PMID:32553695 NCBI chr 2:264,266,959...264,293,040
Ensembl chr 2:264,266,984...264,293,046
JBrowse link
G Ctnnb1 catenin beta 1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and affects the localization of CTNNB1 protein; mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and affects the localization of CTNNB1 protein]; SP1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 protein]
CTD PMID:29663660 NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
JBrowse link
G Ctsd cathepsin D increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSD mRNA CTD PMID:12097258 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
JBrowse link
G Ctsw cathepsin W increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSW mRNA CTD PMID:19480007 NCBI chr 1:220,844,579...220,847,967
Ensembl chr 1:220,844,558...220,848,153
JBrowse link
G Cubn cubilin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CUBN mRNA CTD PMID:32553695 NCBI chr17:80,584,921...80,807,181
Ensembl chr17:80,584,878...80,807,243
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CXCL10 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCL10 mRNA
CTD PMID:27891153, PMID:32553695 NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CXCL13 mRNA CTD PMID:21785161 NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CXCL1 mRNA CTD PMID:32553695 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
JBrowse link
G Cxcr6 C-X-C motif chemokine receptor 6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCR6 mRNA CTD PMID:32553695 NCBI chr 8:132,869,712...132,870,766
Ensembl chr 8:132,869,712...132,870,767
JBrowse link
G Cyb5a cytochrome b5 type A multiple interactions
increases expression
EXP tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein] CTD PMID:24995432, PMID:27091720 NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CYB5R3 mRNA CTD PMID:21785161 NCBI chr 7:124,024,003...124,041,564
Ensembl chr 7:124,023,995...124,041,594
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases response to substance
increases metabolic processing
increases expression
multiple interactions
affects response to substance
increases activity
ISO
EXP
CYP1A1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein
7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 mRNA]; 7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 mRNA; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein; Estradiol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; resveratrol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]
CYP1A1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein
2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 5-androstene-16-fluoro-17-one inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 7-ketocholesterol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein binds to CYP1A1 promoter]]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene; Dehydroepiandrosterone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; Dehydroepiandrosterone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]
1-(1-propynyl)pyrene inhibits the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [[benzo(c)phenanthrene results in increased expression of CYP1A1 protein] promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which results in decreased expression of CYP1A1; [benzo(c)phenanthrene promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CYP1A1 mRNA; [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
CTD PMID:7756127, PMID:8674863, PMID:8961944, PMID:9168260, PMID:10051580, PMID:10496959, PMID:10496962, PMID:10575002, PMID:10581206, PMID:11042205, PMID:11559018, PMID:12097275, PMID:12117779, PMID:15331171, PMID:15596260, PMID:15667830, PMID:16054776, PMID:16903077, PMID:17183067, PMID:17275817, PMID:18205319, PMID:19276279, PMID:20507880, PMID:22595614, PMID:25110319, PMID:25697376, PMID:26945725, PMID:27869817, PMID:27891153, PMID:32159784, PMID:32553695 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity
multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein
2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]
CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:8961944, PMID:15606143, PMID:16054776, PMID:17183067, PMID:19276279, PMID:25110319 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases activity
increases metabolic processing
increases expression
multiple interactions
affects response to substance
increases response to substance
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein
CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA
2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 2,4,3',5'-tetramethoxystilbene inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; 2,4,3',5'-tetramethoxystilbene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 5-androstene-16-fluoro-17-one inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [[benzo(c)phenanthrene results in increased expression of CYP1B1 protein] promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; alpha-naphthoflavone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein
Estradiol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; POMC protein promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
1-ethynylpyrene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1B1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Dietary Fats] results in decreased expression of CYP1B1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of AHRR mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CREB3L3 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CXCL10 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CYP1A1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of EGR2 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of ERDR1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HBB-B1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HOXB6 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HSPA1A mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of IL6 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of NR4A1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of POLR2A mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of RAG1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SOX19 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SPP1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of TNF mRNA; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; chelerythrine inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Dehydroepiandrosterone inhibits the reaction [benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; Dehydroepiandrosterone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Dehydroepiandrosterone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Tetradecanoylphorbol Acetate inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein
CYP1B1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; CYP1B1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
CYP1B1 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:7505439, PMID:7588239, PMID:8033136, PMID:8674863, PMID:9168260, PMID:10037446, PMID:10497882, PMID:10581206, PMID:11323178, PMID:11376689, PMID:11559018, PMID:12097275, PMID:12117779, PMID:15331171, PMID:15580705, PMID:15596260, PMID:15606143, PMID:15667830, PMID:15843505, PMID:17183067, PMID:17275817, PMID:17442664, PMID:18205319, PMID:19276279, PMID:19750107, PMID:20103723, PMID:20171256, PMID:21252291, PMID:22595614, PMID:25110319, PMID:26945725, PMID:27891153, PMID:32159784, PMID:32553695 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases activity
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein]
CTD PMID:16054776 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases activity
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein]
CTD PMID:16054776 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO CYP2B6 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:32159784 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 multiple interactions ISO CYP2C19 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:32159784 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases response to substance ISO CYP2D6 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:20507880 NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects response to substance
increases expression
ISO
EXP
CYP2E1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP2E1 mRNA
CTD PMID:18622027, PMID:24576726 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 multiple interactions ISO [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:19713358 NCBI chr 1:82,595,211...82,610,350
Ensembl chr 1:82,595,211...82,610,350
JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of DARS mRNA CTD PMID:21785161 NCBI chr13:45,074,067...45,127,815
Ensembl chr13:45,074,072...45,127,815
JBrowse link
G Dazl deleted in azoospermia-like decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DAZL mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]
CTD PMID:20562217 NCBI chr 9:12,633,983...12,651,017
Ensembl chr 9:12,633,990...12,650,938
JBrowse link
G Dbi diazepam binding inhibitor, acyl-CoA binding protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DBI mRNA CTD PMID:12376462 NCBI chr13:36,147,667...36,156,076
Ensembl chr13:36,117,119...36,174,908
JBrowse link
G Dchs1 dachsous cadherin-related 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DCHS1 mRNA CTD PMID:19480007 NCBI chr 1:170,594,981...170,629,062
Ensembl chr 1:170,594,822...170,628,915
JBrowse link
G Dcn decorin multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of DCN protein CTD PMID:22248470 NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323
JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DCXR mRNA CTD PMID:32553695 NCBI chr10:109,906,119...109,909,696
Ensembl chr10:109,906,815...109,909,715
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT3 mRNA CTD PMID:32553695 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DDIT4 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT4 mRNA
CTD PMID:32553695 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT4L mRNA CTD PMID:32553695 NCBI chr 2:242,882,219...242,885,088
Ensembl chr 2:242,882,306...242,885,131
JBrowse link
G Ddx39b DExD-box helicase 39B multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of DDX39B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX39B protein
CTD PMID:22248470 NCBI chr20:4,806,103...4,818,600
Ensembl chr20:4,806,108...4,818,568
JBrowse link
G Ddx4 DEAD-box helicase 4 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DDX4 mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]
CTD PMID:20562217 NCBI chr 2:44,447,610...44,504,263
Ensembl chr 2:44,447,573...44,504,354
JBrowse link
G Ddx5 DEAD-box helicase 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX5 mRNA CTD PMID:21785161 NCBI chr10:94,979,759...94,988,461
Ensembl chr10:94,980,928...94,988,461
JBrowse link
G Des desmin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DES mRNA CTD PMID:12376462 NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DHCR7 mRNA CTD PMID:32553695 NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
JBrowse link
G Dicer1 dicer 1 ribonuclease III increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]
CTD PMID:24792773 NCBI chr 6:128,388,084...128,453,234
Ensembl chr 6:128,388,053...128,434,183
JBrowse link
G Dido1 death inducer-obliterator 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DIDO1 mRNA CTD PMID:32553695 NCBI chr 3:176,162,886...176,216,868
Ensembl chr 3:176,162,886...176,197,753
JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DIO3 mRNA CTD PMID:32553695 NCBI chr 6:134,627,278...134,629,139
Ensembl chr 6:134,627,278...134,629,138
JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNAJB6 mRNA CTD PMID:21785161 NCBI chr 4:2,711,329...2,774,969
Ensembl chr 4:2,711,385...2,774,890
JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DNAJC9 mRNA CTD PMID:32553695 NCBI chr15:4,356,512...4,360,788
Ensembl chr15:4,356,261...4,360,564
JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein
CTD PMID:12097258, PMID:24792773 NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
JBrowse link
G Dock9 dedicator of cytokinesis 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DOCK9 mRNA CTD PMID:32553695 NCBI chr15:107,945,664...108,210,967
Ensembl chr15:107,945,664...108,210,826
JBrowse link
G Dok1 docking protein 1 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DOK1 mRNA CTD PMID:32553695 NCBI chr 4:113,864,211...113,866,695
Ensembl chr 4:113,864,215...113,866,674
JBrowse link
G Dpt dermatopontin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DPT mRNA CTD PMID:19480007 NCBI chr13:83,073,307...83,102,404
Ensembl chr13:83,073,544...83,102,401
JBrowse link
G Dpysl4 dihydropyrimidinase-like 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DPYSL4 mRNA CTD PMID:21527772 NCBI chr 1:211,423,022...211,438,533
Ensembl chr 1:211,423,022...211,438,531
JBrowse link
G Dynll2 dynein light chain LC8-type 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of DYNLL2 mRNA CTD PMID:21785161 NCBI chr10:75,262,536...75,281,302
Ensembl chr10:75,262,537...75,270,561
JBrowse link
G Dyrk3 dual specificity tyrosine phosphorylation regulated kinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DYRK3 mRNA CTD PMID:32553695 NCBI chr13:47,906,230...47,916,877
Ensembl chr13:47,906,231...47,916,877
JBrowse link
G E2f8 E2F transcription factor 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of E2F8 mRNA CTD PMID:32553695 NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591
JBrowse link
G Ecrg4 ECRG4 augurin precursor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ECRG4 mRNA CTD PMID:19480007 NCBI chr 9:50,526,811...50,548,056
Ensembl chr 9:50,526,811...50,548,046
JBrowse link
G Eda2r ectodysplasin A2 receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EDA2R mRNA CTD PMID:32553695 NCBI chr  X:66,560,200...66,602,509
Ensembl chr  X:66,561,286...66,602,506
JBrowse link
G Ednrb endothelin receptor type B decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EDNRB mRNA CTD PMID:19480007 NCBI chr15:88,004,775...88,036,354
Ensembl chr15:88,006,977...88,036,354
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EEF1A1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EEF1A1 protein
CTD PMID:12376462, PMID:20045496 NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
JBrowse link
G Eef2 eukaryotic translation elongation factor 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EEF2 mRNA CTD PMID:21785161 NCBI chr 7:11,401,501...11,406,771
Ensembl chr 7:11,401,501...11,406,771
JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EFEMP1 mRNA CTD PMID:12376462 NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
JBrowse link
G Efnb2 ephrin B2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EFNB2 mRNA CTD PMID:32553695 NCBI chr16:86,631,151...86,672,050
Ensembl chr16:86,631,064...86,675,049
JBrowse link
G Egfr epidermal growth factor receptor decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of EGFR mRNA CTD PMID:32553695 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Egr1 early growth response 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EGR1 mRNA CTD PMID:19480007 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of EGR2 mRNA CTD PMID:27891153 NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EI24 mRNA CTD PMID:32553695 NCBI chr 8:39,254,883...39,271,238
Ensembl chr 8:39,254,889...39,266,959
JBrowse link
G Eif4b eukaryotic translation initiation factor 4B affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4B mRNA CTD PMID:21785161 NCBI chr 7:143,679,656...143,701,452
Ensembl chr 7:143,679,617...143,701,452
JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4G2 mRNA CTD PMID:21785161 NCBI chr 1:175,883,362...175,895,510
Ensembl chr 1:175,883,363...175,895,510
JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EMP1 mRNA CTD PMID:21527772 NCBI chr 4:169,161,076...169,181,967
Ensembl chr 4:169,147,243...169,181,966
JBrowse link
G Emp3 epithelial membrane protein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EMP3 mRNA CTD PMID:21527772 NCBI chr 1:101,900,731...101,903,948
Ensembl chr 1:101,900,733...101,903,910
JBrowse link
G Eno1 enolase 1 multiple interactions
increases expression
decreases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ENO1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ENO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ENO1 protein
CTD PMID:12376462, PMID:22248470 NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
JBrowse link
G Enox1 ecto-NOX disulfide-thiol exchanger 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENOX1 mRNA CTD PMID:32553695 NCBI chr15:59,331,134...59,884,512
Ensembl chr15:59,678,165...59,884,511
JBrowse link
G Enox2 ecto-NOX disulfide-thiol exchanger 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENOX2 mRNA CTD PMID:32553695 NCBI chr  X:135,918,938...136,303,267
Ensembl chr  X:135,918,929...136,303,249
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENPP2 mRNA CTD PMID:32553695 NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
JBrowse link
G Epb41l4b erythrocyte membrane protein band 4.1 like 4B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of EPB41L4B mRNA CTD PMID:32553695 NCBI chr 5:74,030,950...74,192,275
Ensembl chr 5:74,030,882...74,191,167
JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression
decreases expression
affects response to substance
increases response to substance
ISO
EXP
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EPHX1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EPHX1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPHX1 mRNA
EPHX1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
EPHX1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; EPHX1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
[cyclohexene oxide results in decreased activity of EPHX1 protein] which results in decreased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:8961944, PMID:11323178, PMID:12376462, PMID:15331171, PMID:17204581, PMID:17442664, PMID:19027032, PMID:24576726 NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
JBrowse link
G Epo erythropoietin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPO mRNA CTD PMID:19502547 NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]
CTD PMID:23717041 NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
JBrowse link
G Erp29 endoplasmic reticulum protein 29 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ERP29 protein CTD PMID:22248470 NCBI chr12:40,619,377...40,625,884
Ensembl chr12:40,619,377...40,625,883
JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ESCO2 mRNA CTD PMID:32553695 NCBI chr15:42,500,929...42,519,019
Ensembl chr15:42,500,929...42,518,855
JBrowse link
G Esr1 estrogen receptor 1 decreases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ESR1 protein
[Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein; [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein
CTD PMID:16891317 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Evi2a ecotropic viral integration site 2A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EVI2A mRNA CTD PMID:32553695 NCBI chr10:66,870,048...66,873,948
Ensembl chr10:66,870,067...66,873,948
JBrowse link
G Exoc3l4 exocyst complex component 3-like 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EXOC3L4 mRNA CTD PMID:19480007 NCBI chr 6:135,866,132...135,880,724
Ensembl chr 6:135,866,739...135,880,721
JBrowse link
G Ezr ezrin multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of EZR protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EZR mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EZR protein
CTD PMID:12376462, PMID:22248470 NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
JBrowse link
G Fas Fas cell surface death receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FAS mRNA CTD PMID:32553695 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
JBrowse link
G Fasn fatty acid synthase multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FASN protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of FASN protein
CTD PMID:22248470 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
JBrowse link
G Fbn2 fibrillin 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FBN2 mRNA CTD PMID:19480007 NCBI chr18:53,068,495...53,272,254
Ensembl chr18:53,068,495...53,181,503
JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FDPS mRNA CTD PMID:32553695 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase decreases expression
increases methylation
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FHIT mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FHIT protein
9,10-Dimethyl-1,2-benzanthracene results in increased methylation of FHIT intron; 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of FHIT promoter
CTD PMID:15937960 NCBI chr15:15,697,292...16,862,873 JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FHL2 mRNA CTD PMID:19480007 NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
JBrowse link
G Fhod3 formin homology 2 domain containing 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FHOD3 mRNA CTD PMID:32553695 NCBI chr18:16,650,786...17,332,209
Ensembl chr18:16,650,806...17,332,210
JBrowse link
G Flnc filamin C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FLNC mRNA CTD PMID:21527772 NCBI chr 4:56,710,934...56,738,779
Ensembl chr 4:56,711,049...56,738,791
JBrowse link
G Fn1 fibronectin 1 multiple interactions
decreases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FN1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FN1 mRNA
CTD PMID:12376462, PMID:22248470 NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA
[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]
CTD PMID:20103723 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FOSL1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOSL1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of FOSL1 mRNA
CTD PMID:20025956, PMID:32553695 NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
JBrowse link
G Foxn3 forkhead box N3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXN3 mRNA CTD PMID:21785161 NCBI chr 6:123,183,720...123,577,719
Ensembl chr 6:123,187,726...123,577,695
JBrowse link
G Foxo3 forkhead box O3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FOXO3 protein CTD PMID:21785161 NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
JBrowse link
G Frat2 FRAT regulator of WNT signaling pathway 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FRAT2 mRNA CTD PMID:32553695 NCBI chr 1:261,088,504...261,091,690
Ensembl chr 1:261,089,745...261,090,437
JBrowse link
G Furin furin (paired basic amino acid cleaving enzyme) increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FURIN mRNA CTD PMID:12376462 NCBI chr 1:142,185,092...142,198,167
Ensembl chr 1:142,185,094...142,197,182
JBrowse link
G Fus FUS RNA binding protein affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of FUS mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FUS mRNA
CTD PMID:19480007, PMID:21785161 NCBI chr 1:199,412,805...199,426,705
Ensembl chr 1:199,412,834...199,426,702
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha multiple interactions
increases expression
ISO [epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GADD45A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA
CTD PMID:23717041, PMID:32553695 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
JBrowse link
G Galnt13 polypeptide N-acetylgalactosaminyltransferase 13 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GALNT13 mRNA CTD PMID:32553695 NCBI chr 3:39,967,056...40,625,144
Ensembl chr 3:40,038,336...40,624,530
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase decreases expression
increases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GAPDH mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAPDH protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of GAPDH protein
CTD PMID:19502547, PMID:22248470 NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
JBrowse link
G Gas5 growth arrest specific 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAS5 mRNA CTD PMID:19480007 NCBI chr13:78,852,523...78,855,844 JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GBE1 mRNA CTD PMID:32553695 NCBI chr11:7,210,169...7,485,895
Ensembl chr11:7,210,209...7,485,890
JBrowse link
G Gbp5 guanylate binding protein 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GBP5 mRNA CTD PMID:19480007 NCBI chr 2:248,178,441...248,196,873
Ensembl chr 2:248,178,389...248,197,160
JBrowse link
G Gchfr GTP cyclohydrolase I feedback regulator increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GCHFR mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GCHFR mRNA
CTD PMID:32553695 NCBI chr 3:110,975,923...110,979,957
Ensembl chr 3:110,975,923...110,979,957
JBrowse link
G Gda guanine deaminase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GDA mRNA CTD PMID:12376462 NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GDF15 mRNA CTD PMID:32553695 NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GGT1 mRNA CTD PMID:12376462 NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
JBrowse link
G Ggta1 glycoprotein, alpha-galactosyltransferase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GGTA1 mRNA CTD PMID:32553695 NCBI chr 3:14,614,099...14,701,185
Ensembl chr 3:14,614,122...14,644,951
JBrowse link
G Gh1 growth hormone 1 decreases response to substance EXP GH1 gene mutant form results in decreased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:12082019 NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180
JBrowse link
G Gimap5 GTPase, IMAP family member 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GIMAP5 mRNA CTD PMID:19480007 NCBI chr 4:78,377,228...78,386,683
Ensembl chr 4:78,378,144...78,385,577
JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions
decreases expression
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] affects the expression of GJA1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of GJA1 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of GJA1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GJA1 mRNA; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA1 protein
CTD PMID:7586191, PMID:24269759, PMID:25447408 NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression
multiple interactions
increases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA4 protein
9,10-Dimethyl-1,2-benzanthracene affects the reaction [A gene mutant form results in decreased expression of GJA4 protein]; [A gene mutant form co-treated with 9,10-Dimethyl-1,2-benzanthracene] affects the expression of GJA4 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA4 protein
CTD PMID:24269759, PMID:25447408 NCBI chr 5:145,374,688...145,377,221
Ensembl chr 5:145,374,690...145,377,221
JBrowse link
G Gjb2 gap junction protein, beta 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] affects the expression of GJB2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of GJB2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GJB2 mRNA CTD PMID:7586191 NCBI chr15:37,377,313...37,394,494
Ensembl chr15:37,377,316...37,383,277
JBrowse link
G Gjb5 gap junction protein, beta 5 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GJB5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GJB5 mRNA
CTD PMID:7586191, PMID:32553695 NCBI chr 5:145,422,034...145,440,558
Ensembl chr 5:145,422,357...145,423,172
JBrowse link
G Gls glutaminase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GLS mRNA CTD PMID:21527772 NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872
JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GMDS mRNA CTD PMID:32553695 NCBI chr17:33,408,722...33,938,086
Ensembl chr17:33,408,722...33,938,085
JBrowse link
G Gng12 G protein subunit gamma 12 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GNG12 mRNA CTD PMID:19480007 NCBI chr 4:97,634,925...97,763,478
Ensembl chr 4:97,657,671...97,760,102
JBrowse link
G Gp2 glycoprotein 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GP2 mRNA CTD PMID:19480007 NCBI chr 1:189,166,735...189,182,306
Ensembl chr 1:189,166,399...189,182,306
JBrowse link
G Gpc6 glypican 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GPC6 mRNA CTD PMID:32553695 NCBI chr15:102,164,091...103,174,721
Ensembl chr15:102,164,751...103,170,847
JBrowse link
G Gphn gephyrin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GPHN mRNA CTD PMID:32553695 NCBI chr 6:101,327,874...101,859,169
Ensembl chr 6:101,532,518...101,859,164
JBrowse link
G Gpr68 G protein-coupled receptor 68 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPR68 mRNA CTD PMID:19480007 NCBI chr 6:124,874,151...124,903,949
Ensembl chr 6:124,874,151...124,876,710
JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA CTD PMID:32553695 NCBI chr 4:168,832,937...168,851,650
Ensembl chr 4:168,832,910...168,851,652
JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX2 protein CTD PMID:18056462 NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases expression
decreases activity
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of GSR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of GSR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of GSR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of GSR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of GSR protein; geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein
allyl isothiocyanate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]
CTD PMID:20691676, PMID:23033690, PMID:24995432, PMID:25744308, PMID:31476248 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
JBrowse link
G Gss glutathione synthetase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSS mRNA CTD PMID:12376462 NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
JBrowse link
G Gstp1 glutathione S-transferase pi 1 affects response to substance
increases expression
decreases expression
multiple interactions
EXP GSTP1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTP1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of GSTP1 protein
CTD PMID:12097258, PMID:22406437, PMID:24576726 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Gtdc1 glycosyltransferase-like domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GTDC1 mRNA CTD PMID:32553695 NCBI chr 3:29,410,426...29,705,981
Ensembl chr 3:29,410,426...29,705,985
JBrowse link
G Gtse1 G-2 and S-phase expressed 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GTSE1 mRNA CTD PMID:32553695 NCBI chr 7:126,736,416...126,753,221
Ensembl chr 7:126,736,732...126,753,220
JBrowse link
G H1f4 H1.4 linker histone, cluster member multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of H1F4 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H1F4 protein
CTD PMID:22248470 NCBI chr17:43,734,461...43,735,120
Ensembl chr17:43,734,461...43,735,120
JBrowse link
G H2ax H2A.X variant histone increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of H2AX protein modified form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein
A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein]
CTD PMID:23969067, PMID:25448685, PMID:32553695 NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
JBrowse link
G Hal histidine ammonia lyase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of HAL protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of HAL protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of HAL protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of HAL protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of HAL protein CTD PMID:20691676 NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
JBrowse link
G Has2 hyaluronan synthase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of HAS2 mRNA CTD PMID:32553695 NCBI chr 7:96,438,046...96,464,049
Ensembl chr 7:96,438,046...96,464,049
JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HBA1 mRNA CTD PMID:12376462 NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
JBrowse link
G Hbb hemoglobin subunit beta multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HBB-B1 mRNA CTD PMID:27891153 NCBI chr 1:168,971,269...168,972,680
Ensembl chr 1:168,971,274...168,972,725
JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of HBEGF mRNA CTD PMID:32553695 NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
JBrowse link
G Hdac1 histone deacetylase 1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]
CTD PMID:24792773 NCBI chr 5:147,716,664...147,743,723
Ensembl chr 5:147,716,664...147,743,723
JBrowse link
G Hells helicase, lymphoid specific increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HELLS protein CTD PMID:20025956 NCBI chr 1:257,901,856...257,953,889
Ensembl chr 1:257,766,691...257,949,183
Ensembl chr 1:257,766,691...257,949,183
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases activity
affects expression
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased activity of HIF1A protein
9,10-Dimethyl-1,2-benzanthracene affects the expression of HIF1A mRNA
CTD PMID:19502547, PMID:21785161 NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
JBrowse link
G Hist1h2bq histone cluster 1 H2B family member Q multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HIST1H2BQ protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HIST1H2BQ protein
CTD PMID:22248470 NCBI chr17:43,679,925...43,689,311
Ensembl chr17:43,679,925...43,689,311
JBrowse link
G Hist2h2aa3 histone cluster 2 H2A family member A3 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of H2AC18 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AC18 protein
CTD PMID:22248470 NCBI chr 2:198,388,766...198,389,293
Ensembl chr 2:198,388,809...198,389,201
Ensembl chr 2:198,388,809...198,389,201
JBrowse link
G Hmox1 heme oxygenase 1 decreases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein]
CTD PMID:12097258, PMID:24995432 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HNRNPA2B1 mRNA CTD PMID:21785161 NCBI chr 4:81,237,496...81,241,281
Ensembl chr 4:81,237,496...81,241,282
JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HNRNPK mRNA CTD PMID:21785161 NCBI chr17:6,664,730...6,676,753
Ensembl chr17:6,665,659...6,676,654
JBrowse link
G Hnrnpm heterogeneous nuclear ribonucleoprotein M multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HNRNPM protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HNRNPM protein
CTD PMID:22248470 NCBI chr 7:18,516,253...18,554,536
Ensembl chr 7:18,516,512...18,554,227
JBrowse link
G Hoxb6 homeo box B6 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HOXB6 mRNA CTD PMID:27891153 NCBI chr10:84,147,331...84,150,238
Ensembl chr10:84,147,836...84,149,600
JBrowse link
G Hp haptoglobin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of HP mRNA CTD PMID:32553695 NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions
increases mutagenesis
increases response to substance
ISO 4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]
9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene
[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased mutagenesis of HRAS gene; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with geraniol] affects the localization of HRAS protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HRAS protein
CTD PMID:1375869, PMID:3115617, PMID:11241758, PMID:11376698, PMID:12117780, PMID:20103723, PMID:22760862 NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSP90AB1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSP90AB1 protein
CTD PMID:22248470 NCBI chr 9:17,817,791...17,823,163
Ensembl chr 9:17,817,721...17,823,243
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HSPA1A mRNA CTD PMID:27891153 NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSPA5 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA5 protein
CTD PMID:22248470 NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA8 mRNA CTD PMID:21785161 NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of HSPD1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HSPD1 mRNA
CTD PMID:12097258, PMID:21785161 NCBI chr 9:61,680,529...61,691,202
Ensembl chr 9:61,680,530...61,690,956
JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HSPE1 mRNA CTD PMID:12097258 NCBI chr 9:61,691,246...61,724,948
Ensembl chr 9:61,692,154...61,694,599
JBrowse link
G Hspg2 heparan sulfate proteoglycan 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HSPG2 mRNA CTD PMID:21785161 NCBI chr 5:155,812,096...155,913,751 JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ICAM1 mRNA CTD PMID:12097258 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
JBrowse link
G Id3 inhibitor of DNA binding 3, HLH protein decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ID3 mRNA CTD PMID:12376462 NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
JBrowse link
G Ier3 immediate early response 3 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IER3 mRNA
CTD PMID:32553695 NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
JBrowse link
G Ier5 immediate early response 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IER5 mRNA CTD PMID:21527772 NCBI chr13:72,742,210...72,744,302
Ensembl chr13:72,742,210...72,744,303
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with chrysarobin]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Okadaic Acid]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:10365914 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Igf2 insulin-like growth factor 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IGF2 mRNA CTD PMID:19480007 NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
JBrowse link
G Igsf10 immunoglobulin superfamily, member 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IGSF10 mRNA CTD PMID:19480007 NCBI chr 2:149,535,199...149,564,180
Ensembl chr 2:149,533,151...149,564,113
JBrowse link
G Il10 interleukin 10 decreases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL10 protein
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL10 protein]
CTD PMID:31926054 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
JBrowse link
G Il12a interleukin 12A multiple interactions ISO IL12A results in decreased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:22359662 NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
JBrowse link
G Il17ra interleukin 17 receptor A multiple interactions ISO IL17RA results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:22359662 NCBI chr 4:152,995,865...153,018,394
Ensembl chr 4:152,995,865...153,018,394
JBrowse link
G Il17rd interleukin 17 receptor D decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IL17RD mRNA CTD PMID:32553695 NCBI chr16:2,670,471...2,737,271
Ensembl chr16:2,670,618...2,731,808
JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein]
CTD PMID:24995432 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 increases expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1RL1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL1RL1 mRNA
CTD PMID:19480007, PMID:20025956 NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IL1RN mRNA CTD PMID:32553695 NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
JBrowse link
G Il2 interleukin 2 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL2 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein; Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]
CTD PMID:8931739, PMID:25770929 NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
JBrowse link
G Il33 interleukin 33 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL33 mRNA CTD PMID:19480007, PMID:27869817 NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
JBrowse link
G Il4r interleukin 4 receptor multiple interactions
increases expression
ISO AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL4RA] CTD PMID:27869817 NCBI chr 1:196,942,343...196,967,221
Ensembl chr 1:196,942,364...196,967,220
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of IL6 mRNA; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Glucaric Acid co-treated with ursolic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; ursolic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IL6 mRNA
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]
CTD PMID:14678569, PMID:20043298, PMID:23835587, PMID:24995432, PMID:27891153, PMID:31926054, PMID:32553695, PMID:32662567 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Immp2l inner mitochondrial membrane peptidase subunit 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IMMP2L mRNA CTD PMID:32553695 NCBI chr 6:60,958,351...61,859,457 JBrowse link
G Inhbb inhibin subunit beta B increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of INHBB mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of INHBB mRNA
CTD PMID:32553695 NCBI chr13:35,436,532...35,442,222
Ensembl chr13:35,436,532...35,442,222
JBrowse link
G Insig1 insulin induced gene 1 affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of INSIG1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of INSIG1 mRNA
CTD PMID:12376462, PMID:21785161 NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
JBrowse link
G Isg15 ISG15 ubiquitin-like modifier increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ISG15 mRNA CTD PMID:21527772 NCBI chr 5:173,624,862...173,629,124
Ensembl chr 5:173,624,310...173,626,248
JBrowse link
G Itgb3 integrin subunit beta 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ITGB3 mRNA CTD PMID:32553695 NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
JBrowse link
G Itgb6 integrin subunit beta 6 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ITGB6 mRNA CTD PMID:19480007 NCBI chr 3:46,652,624...46,775,362
Ensembl chr 3:46,652,623...46,726,958
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ITPR1 mRNA CTD PMID:32553695 NCBI chr 4:140,247,297...140,580,749
Ensembl chr 4:140,247,313...140,580,748
JBrowse link
G Ivns1abp influenza virus NS1A binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of IVNS1ABP mRNA CTD PMID:21785161 NCBI chr13:68,702,970...68,722,472
Ensembl chr13:68,702,820...68,722,472
JBrowse link
G Jchain joining chain of multimeric IgA and IgM decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of JCHAIN mRNA CTD PMID:19480007 NCBI chr14:21,176,841...21,183,731
Ensembl chr14:21,177,237...21,183,542
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of JUN protein
[Glucaric Acid co-treated with resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; [Glucaric Acid co-treated with ursolic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; ursolic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of JUN protein modified form
CTD PMID:20025956, PMID:22406437, PMID:23835587 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein]
CTD PMID:24995432 NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
JBrowse link
G Kif1a kinesin family member 1A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KIF1A mRNA CTD PMID:21527772 NCBI chr 9:100,171,851...100,253,626
Ensembl chr 9:100,171,772...100,253,609
JBrowse link
G Kif21a kinesin family member 21A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KIF21A mRNA CTD PMID:32553695 NCBI chr 7:132,069,962...132,200,947
Ensembl chr 7:132,071,116...132,143,470
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KIT protein CTD PMID:24576726 NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
JBrowse link
G Kitlg KIT ligand increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KITLG mRNA CTD PMID:24576726 NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
JBrowse link
G Klf10 Kruppel-like factor 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KLF10 mRNA CTD PMID:12097258 NCBI chr 7:77,156,010...77,162,096
Ensembl chr 7:77,156,006...77,162,148
JBrowse link
G Klf4 Kruppel like factor 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KLF4 mRNA CTD PMID:32553695 NCBI chr 5:72,283,311...72,287,669
Ensembl chr 5:72,283,313...72,287,669
JBrowse link
G Klhl29 kelch-like family member 29 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of KLHL29 mRNA CTD PMID:32553695 NCBI chr 6:29,178,858...29,483,460
Ensembl chr 6:29,178,858...29,483,460
JBrowse link
G Kmt2c lysine methyltransferase 2C decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of KMT2C mRNA CTD PMID:32553695 NCBI chr 4:82,506...109,986
NCBI chr 4:6,083,650...6,294,413
Ensembl chr 4:6,083,736...6,292,516
JBrowse link
G Kng2 kininogen 2 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KNG1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KNG2 mRNA
CTD PMID:19480007, PMID:22248470 NCBI chr11:81,509,185...81,516,759 JBrowse link
G Krt19 keratin 19 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT19 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT19 protein
CTD PMID:22248470 NCBI chr10:88,055,843...88,060,560
Ensembl chr10:88,055,841...88,060,561
JBrowse link
G Krt5 keratin 5 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT5 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT5 mRNA
CTD PMID:12376462, PMID:19480007, PMID:22248470 NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
JBrowse link
G Krt8 keratin 8 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT8 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT8 protein
CTD PMID:22248470 NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
JBrowse link
G Krt80 keratin 80 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT80 mRNA CTD PMID:21527772 NCBI chr 7:142,995,715...143,015,932
Ensembl chr 7:142,994,119...143,016,040
JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LAMC2 mRNA CTD PMID:21527772 NCBI chr13:70,566,643...70,632,126
Ensembl chr13:70,566,643...70,626,252
JBrowse link
G Large1 LARGE xylosyl- and glucuronyltransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LARGE mRNA CTD PMID:32553695 NCBI chr19:12,481,563...12,945,320
Ensembl chr19:12,481,540...12,942,963
JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LCK mRNA CTD PMID:19480007 NCBI chr 5:147,750,976...147,779,627
Ensembl chr 5:147,750,973...147,761,983
JBrowse link
G Lgals3 galectin 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of LGALS3 mRNA CTD PMID:21785161 NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
JBrowse link
G Lgals7 galectin 7 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LGALS7 mRNA CTD PMID:21527772 NCBI chr 1:87,044,823...87,047,223
Ensembl chr 1:87,045,335...87,047,223
JBrowse link
G Limd1 LIM domains containing 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LIMD1 mRNA CTD PMID:19480007 NCBI chr 8:132,553,218...132,598,826
Ensembl chr 8:132,553,218...132,598,812
JBrowse link
G Lin7a lin-7 homolog A, crumbs cell polarity complex component decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LIN7A mRNA CTD PMID:12376462 NCBI chr 7:49,429,613...49,627,835
Ensembl chr 7:49,385,705...49,656,856
JBrowse link
G Lmna lamin A/C multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of LMNA protein CTD PMID:22248470 NCBI chr 2:187,842,884...187,863,552
Ensembl chr 2:187,842,885...187,863,516
JBrowse link
G Lpl lipoprotein lipase decreases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LPL mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of LPL mRNA
CTD PMID:12376462, PMID:32553695 NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
JBrowse link
G Lsr lipolysis stimulated lipoprotein receptor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSR mRNA CTD PMID:12376462 NCBI chr 1:89,383,515...89,399,041
Ensembl chr 1:89,383,519...89,399,041
JBrowse link
G Lss lanosterol synthase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LSS mRNA CTD PMID:32553695 NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
JBrowse link
G Ltc4s leukotriene C4 synthase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LTC4S mRNA CTD PMID:19480007 NCBI chr10:35,736,486...35,743,088
Ensembl chr10:35,737,664...35,739,625
JBrowse link
G Ly6e lymphocyte antigen 6 family member E affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of LY6E mRNA CTD PMID:21785161 NCBI chr 7:116,355,426...116,359,862
Ensembl chr 7:116,355,698...116,359,862
JBrowse link
G Lypd1 Ly6/Plaur domain containing 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LYPD1 mRNA CTD PMID:19480007 NCBI chr13:42,219,884...42,263,024
Ensembl chr13:42,219,887...42,263,024
JBrowse link
G Lyrm4 LYR motif containing 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LYRM4 mRNA CTD PMID:32553695 NCBI chr17:29,439,042...29,552,773
Ensembl chr17:29,438,980...29,552,790
JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LYVE1 mRNA CTD PMID:19480007 NCBI chr 1:175,663,266...175,676,699
Ensembl chr 1:175,663,266...175,676,699
JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAEA mRNA CTD PMID:21785161 NCBI chr14:82,664,248...82,697,673
Ensembl chr14:82,664,249...82,697,673
JBrowse link
G Mafb MAF bZIP transcription factor B decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MAFB mRNA CTD PMID:19480007 NCBI chr 3:156,338,993...156,340,913
Ensembl chr 3:156,339,004...156,340,913
JBrowse link
G Magi1 membrane associated guanylate kinase, WW and PDZ domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MAGI1 mRNA CTD PMID:32553695 NCBI chr 4:125,684,816...126,300,013
Ensembl chr 4:125,687,307...125,958,112
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein] CTD PMID:22760862 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein] CTD PMID:22760862 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mat2a methionine adenosyltransferase 2A affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAT2A mRNA CTD PMID:21785161 NCBI chr 4:100,297,478...100,303,047
Ensembl chr 4:100,296,075...100,303,080
JBrowse link
G Mcm3 minichromosome maintenance complex component 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MCM3 protein CTD PMID:20025956 NCBI chr 9:26,914,057...26,932,201
Ensembl chr 9:26,914,057...26,932,201
JBrowse link
G Mdh2 malate dehydrogenase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDH2 mRNA CTD PMID:12376462 NCBI chr12:23,941,451...23,954,406
Ensembl chr12:23,941,448...23,954,431
JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MDM2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]
CTD PMID:23717041, PMID:32553695 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
JBrowse link
G Megf6 multiple EGF-like-domains 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MEGF6 mRNA CTD PMID:19480007 NCBI chr 5:171,588,901...171,620,947
Ensembl chr 5:171,472,273...171,620,947
JBrowse link
G Mgarp mitochondria-localized glutamic acid-rich protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MGARP mRNA CTD PMID:19480007 NCBI chr 2:140,444,963...140,453,719
Ensembl chr 2:140,444,965...140,453,107
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions ISO MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:12663516 NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
JBrowse link
G Mgp matrix Gla protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MGP mRNA CTD PMID:12376462 NCBI chr 4:170,856,783...170,860,105
Ensembl chr 4:170,856,751...170,860,225
JBrowse link
G Mif macrophage migration inhibitory factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MIF mRNA CTD PMID:12376462 NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
JBrowse link
G Mir3545 microRNA 3545 affects expression
multiple interactions
increases methylation
ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]
CTD PMID:24792773 NCBI chr 6:136,704,947...136,705,061
Ensembl chr 6:136,704,947...136,705,061
JBrowse link
G Misp3 MISP family member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MISP3 mRNA CTD PMID:19480007 NCBI chr19:25,132,089...25,135,041
Ensembl chr19:25,132,094...25,134,055
JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions EXP 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]] CTD PMID:16891317, PMID:26945725 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
JBrowse link
G Mlf2 myeloid leukemia factor 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MLF2 mRNA CTD PMID:21785161 NCBI chr 4:157,452,578...157,457,254
Ensembl chr 4:157,452,607...157,457,249
JBrowse link
G Mme membrane metallo-endopeptidase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MME mRNA CTD PMID:19480007 NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738
JBrowse link
G Mmp12 matrix metallopeptidase 12 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP12 mRNA CTD PMID:19480007 NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493
JBrowse link
G Mmp13 matrix metallopeptidase 13 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP13 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP13 protein CTD PMID:19480007 NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
JBrowse link
G Mmp14 matrix metallopeptidase 14 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MMP14 mRNA CTD PMID:19480007 NCBI chr15:33,074,441...33,083,666
Ensembl chr15:33,074,441...33,083,655
JBrowse link
G Mmp7 matrix metallopeptidase 7 decreases expression
increases expression
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MMP7 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP7 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP7 protein
CTD PMID:19480007 NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
JBrowse link
G Mmp9 matrix metallopeptidase 9 affects expression
multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of MMP9 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of MMP9 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of MMP9 protein; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]
CTD PMID:12208745, PMID:21785161, PMID:31332895 NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
JBrowse link
G Mpo myeloperoxidase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with cumene hydroperoxide] results in increased activity of MPO protein CTD PMID:14972014 NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
JBrowse link
G Mr1 major histocompatibility complex, class I-related increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MR1 mRNA CTD PMID:21527772 NCBI chr13:72,771,992...72,789,861
Ensembl chr13:72,771,984...72,789,841
JBrowse link
G Msra methionine sulfoxide reductase A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MSRA mRNA CTD PMID:32553695 NCBI chr15:47,488,333...47,800,662
Ensembl chr15:47,488,894...47,800,024
JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COX1 mRNA CTD PMID:12376462 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
JBrowse link
G Mt1 metallothionein 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MT1 mRNA CTD PMID:19480007 NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
JBrowse link
G Mto1 mitochondrial tRNA translation optimization 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTO1 mRNA CTD PMID:19480007 NCBI chr 8:85,807,703...85,832,263
Ensembl chr 8:85,808,125...85,831,937
JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases expression
increases expression
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTOR protein modified form
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MTOR protein modified form
CTD PMID:21785161 NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
JBrowse link
G Muc1 mucin 1, cell surface associated decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MUC1 mRNA CTD PMID:19480007 NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein
CTD PMID:20537511, PMID:24792773, PMID:29663660, PMID:32553695 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
JBrowse link
G Myh9 myosin, heavy chain 9 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYH9 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of MYH9 protein
CTD PMID:22248470 NCBI chr 7:118,740,005...118,792,507
Ensembl chr 7:118,741,110...118,792,625
JBrowse link
G Mylk myosin light chain kinase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MYLK mRNA CTD PMID:32553695 NCBI chr11:69,013,060...69,260,039
Ensembl chr11:69,013,050...69,223,158
JBrowse link
G N4bp1 Nedd4 binding protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of N4BP1 mRNA CTD PMID:32553695 NCBI chr19:21,218,123...21,268,539
Ensembl chr19:21,218,465...21,266,964
JBrowse link
G Ncald neurocalcin delta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NCALD mRNA CTD PMID:32553695 NCBI chr 7:76,199,305...76,632,847
Ensembl chr 7:76,199,306...76,488,216
JBrowse link
G Ncam1 neural cell adhesion molecule 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NCAM1 mRNA CTD PMID:32553695 NCBI chr 8:53,836,797...54,134,881
Ensembl chr 8:53,839,098...53,901,358
JBrowse link
G Ncmap noncompact myelin associated protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NCMAP mRNA CTD PMID:19480007 NCBI chr 5:153,729,250...153,737,161
Ensembl chr 5:153,729,250...153,737,161
JBrowse link
G Nell1 neural EGFL like 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NELL1 mRNA CTD PMID:19480007 NCBI chr 1:105,348,577...106,218,970
Ensembl chr 1:105,349,069...106,218,958
JBrowse link
G Neto2 neuropilin and tolloid like 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NETO2 mRNA CTD PMID:21527772 NCBI chr19:22,450,579...22,486,530
Ensembl chr19:22,450,030...22,486,531
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases expression
multiple interactions
increases activity
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFE2L2 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NFE2L2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased activity of NFE2L2 protein
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein
CTD PMID:22406437, PMID:24995432, PMID:30114225, PMID:32553695 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein; [ursolic acid co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein] CTD PMID:14678569, PMID:23835587 NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression
ISO
EXP
[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFKBIA mRNA
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFKBIA mRNA]
CTD PMID:20043298, PMID:31926054 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
JBrowse link
G Nid1 nidogen 1 affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of NID1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NID1 mRNA
CTD PMID:19480007, PMID:21785161 NCBI chr17:90,553,161...90,627,133
Ensembl chr17:90,553,394...90,627,101
JBrowse link
G Nipsnap2 nipsnap homolog 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NIPSNAP2 mRNA CTD PMID:21785161 NCBI chr12:30,527,540...30,566,090
Ensembl chr12:30,527,540...30,566,032
JBrowse link
G Nkg7 natural killer cell granule protein 7 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NKG7 mRNA CTD PMID:19480007 NCBI chr 1:98,492,873...98,493,940
Ensembl chr 1:98,492,828...98,493,978
JBrowse link
G Nlrp5 NLR family, pyrin domain containing 5 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of NLRP5 mRNA CTD PMID:21785161 NCBI chr 1:71,452,184...71,490,915
Ensembl chr 1:71,453,798...71,486,790
JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein
[Maxepa co-treated with Calcitriol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA]; citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]
CTD PMID:20043298, PMID:20599847, PMID:24995432, PMID:31926054, PMID:32662567 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Notch1 notch receptor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NOTCH1 mRNA CTD PMID:32553695 NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
JBrowse link
G Notch3 notch receptor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NOTCH3 mRNA CTD PMID:32553695 NCBI chr 7:14,138,495...14,189,688
Ensembl chr 7:14,138,495...14,189,688
JBrowse link
G Npr3 natriuretic peptide receptor 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NPR3 mRNA CTD PMID:32553695 NCBI chr 2:61,883,946...61,950,291
Ensembl chr 2:61,888,950...61,949,926
JBrowse link
G Nptx1 neuronal pentraxin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NPTX1 mRNA CTD PMID:19480007 NCBI chr10:108,682,637...108,691,592
Ensembl chr10:108,682,638...108,691,367
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression
multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NQO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NQO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of NQO1 protein; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of NQO1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NQO1 mRNA]
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NQO1 mRNA; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein]
CTD PMID:18694800, PMID:24995432, PMID:25697376, PMID:32553695 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NR2F1 mRNA CTD PMID:19480007 NCBI chr 2:5,569,954...5,579,894
Ensembl chr 2:5,569,935...5,579,894
JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of NR4A1 mRNA CTD PMID:27891153 NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
JBrowse link
G Nsdhl NAD(P) dependent steroid dehydrogenase-like affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of NSDHL mRNA CTD PMID:21785161 NCBI chr  X:152,933,118...152,964,399
Ensembl chr  X:152,933,069...152,964,390
JBrowse link
G Nsmf NMDA receptor synaptonuclear signaling and neuronal migration factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NSMF mRNA CTD PMID:12376462 NCBI chr 3:2,262,173...2,270,996
Ensembl chr 3:2,262,253...2,270,995
JBrowse link
G Ntf3 neurotrophin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NTF3 mRNA CTD PMID:19480007 NCBI chr 4:158,636,883...158,705,886
Ensembl chr 4:158,636,884...158,705,886
JBrowse link
G Nubpl nucleotide binding protein-like decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NUBPL mRNA CTD PMID:32553695 NCBI chr 6:72,891,758...73,147,837
Ensembl chr 6:72,891,725...73,148,536
JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NUSAP1 mRNA CTD PMID:32553695 NCBI chr 3:111,422,267...111,452,600
Ensembl chr 3:111,422,267...111,452,971
JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of OGG1 mRNA
Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of OGG1 mRNA]
CTD PMID:25697376 NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
JBrowse link
G Ogn osteoglycin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of OGN mRNA CTD PMID:19480007 NCBI chr17:14,607,442...14,628,274
Ensembl chr17:15,447,716...15,467,359
Ensembl chr17:15,447,716...15,467,359
JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of OLFML3 protein CTD PMID:22248470 NCBI chr 2:206,219,419...206,222,248
Ensembl chr 2:206,219,419...206,222,248
JBrowse link
G Orm1 orosomucoid 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ORM1 protein CTD PMID:20025956 NCBI chr 5:79,179,668...79,182,820
Ensembl chr 5:79,179,417...79,182,820
JBrowse link
G Otor otoraplin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of OTOR mRNA CTD PMID:32553695 NCBI chr 3:137,154,086...137,157,341
Ensembl chr 3:137,154,086...137,157,341
JBrowse link
G Pabpc1 poly(A) binding protein, cytoplasmic 1 affects expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of PABPC1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of PABPC1 protein
CTD PMID:21785161, PMID:22248470 NCBI chr 7:75,409,581...75,421,874
Ensembl chr 7:75,409,581...75,422,268
JBrowse link
G Padi4 peptidyl arginine deiminase 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PADI4 mRNA CTD PMID:12376462 NCBI chr 5:159,260,675...159,293,906
Ensembl chr 5:159,260,675...159,293,673
JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PAPSS2 mRNA CTD PMID:19480007 NCBI chr 1:251,145,264...251,230,716
Ensembl chr 1:251,145,253...251,230,715
JBrowse link
G Pard6g par-6 family cell polarity regulator gamma increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PARD6G mRNA CTD PMID:32553695 NCBI chr18:76,559,877...76,627,843
Ensembl chr18:76,559,811...76,628,041
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases expression
multiple interactions
increases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PARP1 mRNA
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PARP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PARP1 protein
CTD PMID:23969067, PMID:25448685 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Pcca propionyl-CoA carboxylase subunit alpha decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCCA mRNA CTD PMID:32553695 NCBI chr15:108,960,509...109,306,879
Ensembl chr15:108,960,562...109,306,603
JBrowse link
G Pcdh18 protocadherin 18 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCDH18 mRNA CTD PMID:32553695 NCBI chr 2:138,819,957...138,833,932
Ensembl chr 2:138,819,960...138,833,933
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein]; Masoprocol affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; Tacrolimus affects the reaction [Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein
mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein]
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of PCNA mRNA]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of PCNA mRNA]]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein]
CTD PMID:20043298, PMID:20103723, PMID:22248470, PMID:25770929, PMID:26945725, PMID:27091720, PMID:29663660, PMID:32662567 NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
JBrowse link
G Pcp4 Purkinje cell protein 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCP4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCP4 protein CTD PMID:19480007 NCBI chr11:36,851,035...36,912,272
Ensembl chr11:36,851,038...36,912,229
JBrowse link
G Pcsk6 proprotein convertase subtilisin/kexin type 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCSK6 mRNA CTD PMID:32553695 NCBI chr 1:126,749,508...126,947,392
Ensembl chr 1:126,749,508...126,947,392
JBrowse link
G Pde1a phosphodiesterase 1A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PDE1A mRNA CTD PMID:32553695 NCBI chr 3:66,803,247...67,263,658
Ensembl chr 3:66,803,247...66,885,094
JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PDE4DIP mRNA CTD PMID:32553695 NCBI chr 2:199,867,965...200,066,034
Ensembl chr 2:199,867,972...200,003,443
JBrowse link
G Pdgfa platelet derived growth factor subunit A increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDGFA mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDGFA protein CTD PMID:12376462 NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of PDIA3 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDIA3 protein
CTD PMID:22248470 NCBI chr 3:113,376,983...113,400,707
Ensembl chr 3:113,376,983...113,400,707
JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PDK mRNA CTD PMID:32553695 NCBI chr10:13,446,373...13,525,248
Ensembl chr10:13,451,624...13,515,448
JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PEBP1 mRNA CTD PMID:12376462 NCBI chr12:45,026,948...45,031,148
Ensembl chr12:45,026,886...45,031,145
JBrowse link
G Penk proenkephalin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PENK mRNA CTD PMID:19480007 NCBI chr 5:17,056,412...17,061,762
Ensembl chr 5:17,056,419...17,061,837
JBrowse link
G Pfkm phosphofructokinase, muscle increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PFKM mRNA CTD PMID:19502547 NCBI chr 7:139,702,066...139,722,132
Ensembl chr 7:139,685,573...139,722,132
JBrowse link
G Pgd phosphogluconate dehydrogenase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PGD mRNA CTD PMID:32553695 NCBI chr 5:165,966,128...165,982,327 JBrowse link
G Pglyrp1 peptidoglycan recognition protein 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PGLYRP1 mRNA CTD PMID:21785161 NCBI chr 1:79,790,879...79,796,064
Ensembl chr 1:79,790,705...79,796,111
JBrowse link
G Phb prohibitin increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHB mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHB protein CTD PMID:12376462 NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
JBrowse link
G Phex phosphate regulating endopeptidase homolog, X-linked increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHEX protein CTD PMID:20025956 NCBI chr  X:40,460,047...40,717,982
Ensembl chr  X:40,460,047...40,717,982
JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PHLDA1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA1 mRNA
CTD PMID:32553695 NCBI chr 7:54,247,460...54,249,664
Ensembl chr 7:54,247,460...54,249,664
JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 affects expression
multiple interactions
increases expression
ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PHLDA3 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA3 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PHLDA3 mRNA
CTD PMID:21785161, PMID:32553695 NCBI chr13:52,588,917...52,592,002
Ensembl chr13:52,588,917...52,592,001
JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A multiple interactions
increases mutagenesis
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein
9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA; 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene
CTD PMID:19965957, PMID:20202993, PMID:22923490 NCBI chr  X:31,786,823...31,799,751
Ensembl chr  X:31,786,194...31,799,560
JBrowse link
G Pik3r5 phosphoinositide-3-kinase, regulatory subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PIK3R5 protein CTD PMID:20025956 NCBI chr10:55,013,686...55,078,986
Ensembl chr10:55,013,703...55,080,421
JBrowse link
G Pitx1 paired-like homeodomain 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PITX1 mRNA CTD PMID:19480007 NCBI chr17:8,873,184...8,884,428
Ensembl chr17:8,878,270...8,884,423
JBrowse link
G Plau plasminogen activator, urokinase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLAU mRNA CTD PMID:21527772 NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
JBrowse link
G Plk2 polo-like kinase 2 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLK2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PLK2 mRNA
CTD PMID:12376462, PMID:32553695 NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
JBrowse link
G Plxna2 plexin A2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PLXNA2 mRNA CTD PMID:32553695 NCBI chr13:113,373,569...113,570,774
Ensembl chr13:113,373,578...113,571,648
JBrowse link
G Pnisr PNN interacting serine and arginine rich protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PNISR mRNA CTD PMID:19480007 NCBI chr 5:35,991,028...36,017,952
Ensembl chr 5:35,991,068...36,017,944
JBrowse link
G Polm DNA polymerase mu increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of POLM mRNA CTD PMID:19480007 NCBI chr14:86,069,378...86,079,327
Ensembl chr14:86,069,016...86,078,954
JBrowse link
G Polr2a RNA polymerase II subunit A multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of POLR2A mRNA CTD PMID:27891153 NCBI chr10:56,339,277...56,364,888
Ensembl chr10:56,339,284...56,365,084
JBrowse link
G Pomc proopiomelanocortin multiple interactions EXP POMC protein promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] CTD PMID:7588239 NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions
decreases abundance
ISO POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]
POR protein results in decreased abundance of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:22595614 NCBI chr12:23,998,411...24,017,063
Ensembl chr12:23,998,411...24,046,814
JBrowse link
G Ppfibp2 PPFIA binding protein 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPFIBP2 mRNA CTD PMID:32553695 NCBI chr 1:171,816,231...171,969,117
Ensembl chr 1:171,797,516...171,969,099
JBrowse link
G Ppm1d protein phosphatase, Mg2+/Mn2+ dependent, 1D increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PPM1D mRNA CTD PMID:32553695 NCBI chr10:72,909,550...72,945,884
Ensembl chr10:72,909,550...72,945,884
JBrowse link
G Ppm1l protein phosphatase, Mg2+/Mn2+ dependent, 1L decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPM1L mRNA CTD PMID:32553695 NCBI chr 2:165,932,240...166,218,774
Ensembl chr 2:166,140,112...166,218,774
JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PPP1CB mRNA CTD PMID:21785161 NCBI chr 6:23,548,507...23,581,136
Ensembl chr 6:23,549,317...23,581,052
JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPP1R3C mRNA CTD PMID:32553695 NCBI chr 1:255,371,830...255,376,833
Ensembl chr 1:255,371,810...255,376,833
JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PPP2R1B mRNA CTD PMID:19502547 NCBI chr 8:55,279,278...55,311,768
Ensembl chr 8:55,279,373...55,301,320
JBrowse link
G Ppp2r2b protein phosphatase 2, regulatory subunit B, beta increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PPP2R2B mRNA CTD PMID:19480007 NCBI chr18:36,985,709...37,421,383
Ensembl chr18:36,985,714...37,245,809
JBrowse link
G Prdm1 PR/SET domain 1 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRDM1 mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]
CTD PMID:20562217 NCBI chr20:49,464,921...49,556,623
Ensembl chr20:49,464,919...49,556,518
JBrowse link
G Prdm6 PR/SET domain 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRDM6 mRNA CTD PMID:19480007 NCBI chr18:48,433,747...48,538,834
Ensembl chr18:48,434,652...48,538,023
JBrowse link
G Prdx2 peroxiredoxin 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRDX2 protein CTD PMID:20045496 NCBI chr19:26,084,816...26,090,095
Ensembl chr19:26,084,903...26,090,094
JBrowse link
G Prkcb protein kinase C, beta multiple interactions ISO PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] CTD PMID:10037446 NCBI chr 1:192,233,569...192,575,339
Ensembl chr 1:192,233,910...192,574,831
JBrowse link
G Prkce protein kinase C, epsilon decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRKCE mRNA CTD PMID:32553695 NCBI chr 6:9,483,400...9,973,396
Ensembl chr 6:9,790,422...9,973,396
JBrowse link
G Prkdc protein kinase, DNA-activated, catalytic subunit multiple interactions
decreases expression
increases expression
ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of PRKDC mRNA]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRKDC mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRKDC protein
CTD PMID:25448685 NCBI chr11:89,293,547...89,510,948
Ensembl chr11:89,293,696...89,510,871
JBrowse link
G Prl prolactin increases metabolic processing
increases secretion
multiple interactions
EXP PRL protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased secretion of PRL protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Estradiol] results in increased secretion of PRL protein; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] affects the metabolism of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:3141044, PMID:8674863 NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
JBrowse link
G Procr protein C receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PROCR mRNA CTD PMID:21527772 NCBI chr 3:151,285,321...151,289,581
Ensembl chr 3:151,285,249...151,289,595
JBrowse link
G Prr15 proline rich 15 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRR15 mRNA CTD PMID:32553695 NCBI chr 4:84,478,839...84,481,885
Ensembl chr 4:84,478,839...84,481,883
JBrowse link
G Psrc1 proline and serine rich coiled-coil 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PSRC1 mRNA CTD PMID:32553695 NCBI chr 2:211,176,437...211,181,078
Ensembl chr 2:211,176,556...211,181,123
JBrowse link
G Ptbp1 polypyrimidine tract binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTBP1 mRNA CTD PMID:12376462 NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718
JBrowse link
G Ptger1 prostaglandin E receptor 1 multiple interactions
increases response to substance
ISO celecoxib inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] CTD PMID:21739481 NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTGS2 mRNA; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; [Resveratrol co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; [ursolic acid co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; ursolic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTGS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA
[Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein; citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]
CTD PMID:12208745, PMID:16517061, PMID:16891317, PMID:20043298, PMID:21739481, PMID:23717041, PMID:23835587, PMID:24995432, PMID:31926054, PMID:32553695, PMID:32662567 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Ptms parathymosin affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PTMS mRNA CTD PMID:21785161 NCBI chr 4:157,435,371...157,439,507
Ensembl chr 4:157,435,373...157,439,507
JBrowse link
G Ptn pleiotrophin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTN mRNA CTD PMID:32553695 NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTP4A1 mRNA CTD PMID:32553695 NCBI chr 9:37,223,363...37,254,222
Ensembl chr 9:37,223,729...37,231,291
JBrowse link
G Ptpn13 protein tyrosine phosphatase, non-receptor type 13 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPN13 mRNA CTD PMID:32553695 NCBI chr14:7,688,551...7,863,664
Ensembl chr14:7,688,551...7,863,664
JBrowse link
G Ptpn22 protein tyrosine phosphatase, non-receptor type 22 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTPN22 mRNA CTD PMID:19480007 NCBI chr 2:206,342,066...206,390,348
Ensembl chr 2:206,342,066...206,390,348
JBrowse link
G Ptprcap protein tyrosine phosphatase, receptor type, C-associated protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTPRCAP mRNA CTD PMID:19480007 NCBI chr 1:219,403,970...219,406,129
Ensembl chr 1:219,403,970...219,406,128
JBrowse link
G Ptprg protein tyrosine phosphatase, receptor type, G decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPRG mRNA CTD PMID:32553695 NCBI chr15:12,926,056...13,633,839
Ensembl chr15:12,926,167...13,228,607
JBrowse link
G Ptprm protein tyrosine phosphatase, receptor type, M decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPRM mRNA CTD PMID:32553695 NCBI chr 9:114,846,095...115,555,261
Ensembl chr 9:114,846,095...115,555,261
JBrowse link
G Ptx3 pentraxin 3 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTX3 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTX3 mRNA
CTD PMID:32553695 NCBI chr 2:158,097,843...158,103,653
Ensembl chr 2:158,097,843...158,103,653
JBrowse link
G Rab12 RAB12, member RAS oncogene family affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of RAB12 mRNA CTD PMID:21785161 NCBI chr 9:114,683,985...114,709,613
Ensembl chr 9:114,684,039...114,709,546
JBrowse link
G Rabgap1l RAB GTPase activating protein 1-like decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RABGAP1L mRNA CTD PMID:32553695 NCBI chr13:77,975,392...78,609,009
Ensembl chr13:78,011,047...78,609,045
JBrowse link
G Rad51 RAD51 recombinase increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA
A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RAD51 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein
CTD PMID:23969067, PMID:25448685, PMID:32553695 NCBI chr 3:110,918,240...110,942,920
Ensembl chr 3:110,918,243...110,942,917
JBrowse link
G Rad51ap1 RAD51 associated protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51AP1 protein CTD PMID:20025956 NCBI chr 4:159,469,803...159,482,869
Ensembl chr 4:159,469,804...159,482,869
JBrowse link
G Rad51b RAD51 paralog B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RAD51B mRNA CTD PMID:32553695 NCBI chr 6:102,473,978...103,018,185
Ensembl chr 6:102,477,036...102,512,505
JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein] CTD PMID:22760862 NCBI chr 4:147,532,040...147,592,769
Ensembl chr 4:147,532,042...147,592,699
JBrowse link
G Rag1 recombination activating 1 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of RAG1 mRNA CTD PMID:27891153 NCBI chr 3:91,206,394...91,217,491
Ensembl chr 3:91,206,394...91,217,491
JBrowse link
G Ran RAN, member RAS oncogene family increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAN mRNA CTD PMID:12376462 NCBI chr12:31,319,556...31,324,105
Ensembl chr12:31,320,624...31,323,810
JBrowse link
G Rarres2 retinoic acid receptor responder 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RARRES2 mRNA CTD PMID:19480007 NCBI chr 4:78,205,809...78,208,956
Ensembl chr 4:78,205,812...78,208,767
JBrowse link
G Rb1 RB transcriptional corepressor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RB1 mRNA CTD PMID:32553695 NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
JBrowse link
G Rbp1 retinol binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RBP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RBP1 protein CTD PMID:12376462 NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
JBrowse link
G Rel REL proto-oncogene, NF-kB subunit multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] CTD PMID:14678569 NCBI chr14:108,490,794...108,517,582
Ensembl chr14:108,491,069...108,509,892
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein]
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein
CTD PMID:14678569, PMID:20043298, PMID:24995432, PMID:31926054 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Rerg RAS-like, estrogen-regulated, growth-inhibitor decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RERG mRNA CTD PMID:19480007 NCBI chr 4:171,069,161...171,176,678
Ensembl chr 4:171,069,191...171,176,581
JBrowse link
G RGD1562107 similar to class-alpha glutathione S-transferase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RGD1562107 mRNA CTD PMID:19480007 NCBI chr 9:27,311,229...27,324,452
Ensembl chr 9:27,311,886...27,324,158
JBrowse link
G Ripply3 ripply transcriptional repressor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RIPPLY3 mRNA CTD PMID:21527772 NCBI chr11:34,557,679...34,565,776
Ensembl chr11:34,557,679...34,565,776
JBrowse link
G Rnd1 Rho family GTPase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RND1 mRNA CTD PMID:32553695 NCBI chr 7:140,349,138...140,356,209
Ensembl chr 7:140,349,138...140,356,209
JBrowse link
G Rnf213 ring finger protein 213 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RNF213 mRNA CTD PMID:32553695 NCBI chr10:108,527,351...108,626,372
Ensembl chr10:108,527,740...108,624,688
JBrowse link
G Rpl6 ribosomal protein L6 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPL6 mRNA CTD PMID:12376462 NCBI chr12:40,877,578...40,882,032
Ensembl chr12:40,877,613...40,881,124
JBrowse link
G Rps6 ribosomal protein S6 decreases expression
increases expression
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPS6 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPS6 mRNA
CTD PMID:12097258 NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
JBrowse link
G Rpsa ribosomal protein SA increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPSA protein CTD PMID:22248470 NCBI chr 8:128,806,053...128,809,987
Ensembl chr 8:128,806,129...128,809,986
JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2 mRNA CTD PMID:32553695 NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
JBrowse link
G Rrm2b ribonucleotide reductase regulatory TP53 inducible subunit M2B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2B mRNA CTD PMID:21704725 NCBI chr 7:76,750,045...76,780,817
Ensembl chr 7:76,750,050...76,780,817
JBrowse link
G S100a8 S100 calcium binding protein A8 affects expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of S100A8 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of S100A8 protein
CTD PMID:21785161, PMID:22248470 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S1PR1 mRNA CTD PMID:12376462 NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
JBrowse link
G Sac3d1 SAC3 domain containing 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SAC3D1 mRNA CTD PMID:32553695 NCBI chr 1:221,484,210...221,486,669
Ensembl chr 1:221,484,316...221,486,633
JBrowse link
G Sacs sacsin molecular chaperone increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SACS mRNA CTD PMID:32553695 NCBI chr15:41,448,078...41,530,412
Ensembl chr15:41,448,064...41,530,398
JBrowse link
G Scarb1 scavenger receptor class B, member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SCARB1 mRNA CTD PMID:12376462 NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
JBrowse link
G Scd stearoyl-CoA desaturase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SCD mRNA CTD PMID:12097258, PMID:12376462 NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
JBrowse link
G Scfd2 sec1 family domain containing 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SCFD2 mRNA CTD PMID:32553695 NCBI chr14:36,216,002...36,543,661
Ensembl chr14:36,216,002...36,543,658
JBrowse link
G Scmh1 Scm polycomb group protein homolog 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SCMH1 mRNA CTD PMID:32553695 NCBI chr 5:139,379,256...139,466,805
Ensembl chr 5:139,385,429...139,466,081
JBrowse link
G Sdc4 syndecan 4 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SDC4 mRNA CTD PMID:21785161 NCBI chr 3:160,872,503...160,891,190
Ensembl chr 3:160,872,503...160,891,190
JBrowse link
G Sdcbp syndecan binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SDCBP mRNA CTD PMID:21785161 NCBI chr 5:19,471,664...19,498,499
Ensembl chr 5:19,471,664...19,498,485
JBrowse link
G Sec23a Sec23 homolog A, COPII coat complex component affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SEC23A mRNA CTD PMID:21785161 NCBI chr 6:80,059,742...80,107,340
Ensembl chr 6:80,060,916...80,107,236
JBrowse link
G Selenop selenoprotein P decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SELENOP mRNA CTD PMID:12376462 NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
JBrowse link
G Sfn stratifin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SFN mRNA CTD PMID:21527772 NCBI chr 5:151,823,422...151,824,937
Ensembl chr 5:151,823,887...151,824,633
JBrowse link
G Sfrp2 secreted frizzled-related protein 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SFRP2 mRNA CTD PMID:32553695 NCBI chr 2:182,723,732...182,731,277
Ensembl chr 2:182,723,854...182,731,764
JBrowse link
G Slc12a2 solute carrier family 12 member 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC12A2 mRNA CTD PMID:12376462 NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
JBrowse link
G Slc13a3 solute carrier family 13 member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC13A3 mRNA CTD PMID:19480007 NCBI chr 3:162,084,336...162,147,398
Ensembl chr 3:162,084,315...162,147,393
JBrowse link
G Slc16a2 solute carrier family 16 member 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLC16A2 mRNA CTD PMID:32553695 NCBI chr  X:74,578,600...74,706,068
Ensembl chr  X:74,577,131...74,706,214
JBrowse link
G Slc16a3 solute carrier family 16 member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC16A3 mRNA CTD PMID:19480007 NCBI chr10:110,138,519...110,148,360
Ensembl chr10:110,138,586...110,148,358
JBrowse link
G Slc19a2 solute carrier family 19 member 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC19A2 mRNA CTD PMID:32553695 NCBI chr13:82,552,586...82,566,586
Ensembl chr13:82,552,550...82,566,586
JBrowse link
G Slc1a3 solute carrier family 1 member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC1A3 mRNA CTD PMID:19480007 NCBI chr 2:57,860,881...57,935,363
Ensembl chr 2:57,860,834...57,935,363
JBrowse link
G Slc25a10 solute carrier family 25 member 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC25A10 mRNA CTD PMID:12376462 NCBI chr10:109,665,682...109,674,782
Ensembl chr10:109,665,682...109,673,143
JBrowse link
G Slc38a4 solute carrier family 38, member 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC38A4 mRNA CTD PMID:19480007 NCBI chr 7:138,459,576...138,512,952
Ensembl chr 7:138,459,504...138,512,952
JBrowse link
G Slc39a11 solute carrier family 39, member 11 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLC39A11 mRNA CTD PMID:32553695 NCBI chr10:101,754,842...102,169,100
Ensembl chr10:101,754,830...102,084,035
JBrowse link
G Slc46a3 solute carrier family 46, member 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC46A3 mRNA CTD PMID:32553695 NCBI chr12:8,725,479...8,741,944
Ensembl chr12:8,725,517...8,741,951
JBrowse link
G Slc7a3 solute carrier family 7 member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC7A3 mRNA CTD PMID:19480007 NCBI chr  X:70,972,767...70,979,466
Ensembl chr  X:70,972,765...70,978,952
JBrowse link
G Slit2 slit guidance ligand 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLIT2 mRNA CTD PMID:32553695 NCBI chr14:66,831,848...67,171,491
Ensembl chr14:66,831,848...67,170,361
JBrowse link
G Slit3 slit guidance ligand 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLIT3 mRNA CTD PMID:32553695 NCBI chr10:19,924,200...20,517,918
Ensembl chr10:20,320,878...20,518,518
JBrowse link
G Smyd3 SET and MYND domain containing 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SMYD3 mRNA CTD PMID:32553695 NCBI chr13:97,330,120...97,807,813 JBrowse link
G Snai1 snail family transcriptional repressor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNAI1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNAI1 protein CTD PMID:29663660 NCBI chr 3:164,274,710...164,279,199
Ensembl chr 3:164,274,710...164,279,378
JBrowse link
G Snrnp70 small nuclear ribonucleoprotein U1 subunit 70 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SNRNP70 mRNA CTD PMID:21785161 NCBI chr 1:101,367,470...101,388,153
Ensembl chr 1:101,367,471...101,388,129
JBrowse link
G Snx20 sorting nexin 20 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SNX20 mRNA CTD PMID:32553695 NCBI chr19:19,395,655...19,404,846
Ensembl chr19:19,395,655...19,404,835
JBrowse link
G Sod1 superoxide dismutase 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SOD1 mRNA CTD PMID:24576726 NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
increases expression
ISO
EXP
[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SOD2 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in decreased expression of and results in decreased activity of SOD2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in decreased expression of SOD2 mRNA; SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal]; SOD2 protein results in decreased susceptibility to [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene]
CTD PMID:11507057, PMID:22009531, PMID:24576726 NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
JBrowse link
G Sorbs2 sorbin and SH3 domain containing 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SORBS2 mRNA CTD PMID:32553695 NCBI chr16:49,626,205...49,820,223
Ensembl chr16:49,626,205...49,820,235
JBrowse link
G Sp1 Sp1 transcription factor multiple interactions
increases expression
ISO [[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA; SP1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SP1 protein
CTD PMID:22009531, PMID:29663660 NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
JBrowse link
G Sparcl1 SPARC like 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SPARCL1 mRNA CTD PMID:19480007 NCBI chr14:6,994,261...7,025,309
Ensembl chr14:6,994,190...7,025,308
JBrowse link
G Spink5 serine peptidase inhibitor, Kazal type 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPINK5 mRNA CTD PMID:19480007 NCBI chr18:35,118,300...35,190,458
Ensembl chr18:35,121,967...35,191,069
Ensembl chr 1:35,121,967...35,191,069
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPP1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SPP1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SPP1 mRNA
CTD PMID:19480007, PMID:27891153, PMID:32553695 NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
JBrowse link
G Srsf5 serine and arginine rich splicing factor 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SRSF5 mRNA CTD PMID:21785161 NCBI chr 6:104,611,026...104,640,033
Ensembl chr 6:104,611,026...104,615,302
JBrowse link
G Stat4 signal transducer and activator of transcription 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT4 mRNA CTD PMID:19480007 NCBI chr 9:54,340,649...54,457,753
Ensembl chr 9:54,287,541...54,484,533
JBrowse link
G Stat5a signal transducer and activator of transcription 5A increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT5A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT5A protein CTD PMID:12376462 NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
JBrowse link
G Stk3 serine/threonine kinase 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of STK3 mRNA CTD PMID:21785161 NCBI chr 7:73,617,926...73,883,896
Ensembl chr 7:73,618,644...73,883,812
JBrowse link
G Stmn1 stathmin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STMN1 mRNA CTD PMID:12376462 NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
JBrowse link
G Stmn3 stathmin 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of STMN3 mRNA CTD PMID:21527772 NCBI chr 3:176,808,016...176,816,108
Ensembl chr 3:176,808,017...176,816,162
JBrowse link
G Sulf2 sulfatase 2 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SULF2 mRNA
CTD PMID:32553695 NCBI chr 3:162,791,349...162,872,984
Ensembl chr 3:162,791,355...162,872,831
JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SULT1A1 mRNA CTD PMID:19480007 NCBI chr 1:198,100,586...198,104,106
Ensembl chr 1:198,100,586...198,104,109
JBrowse link
G Sumo3 small ubiquitin-like modifier 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SUMO3 mRNA CTD PMID:21785161 NCBI chr20:11,726,488...11,737,050
Ensembl chr20:11,726,497...11,737,050
JBrowse link
G Taf15 TATA-box binding protein associated factor 15 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TAF15 mRNA CTD PMID:21785161 NCBI chr10:70,689,863...70,721,892
Ensembl chr10:70,689,863...70,721,892
JBrowse link
G Taf9b TATA-box binding protein associated factor 9b increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TAF9B mRNA CTD PMID:19480007 NCBI chr  X:77,281,234...77,295,238
Ensembl chr  X:77,281,210...77,295,426
JBrowse link
G Tagln transgelin multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TAGLN protein CTD PMID:22248470 NCBI chr 8:50,222,895...50,228,369
Ensembl chr 8:50,222,896...50,231,357
JBrowse link
G Tapbp TAP binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TAPBP mRNA CTD PMID:21785161 NCBI chr20:5,468,056...5,476,007
Ensembl chr20:5,468,078...5,476,193
JBrowse link
G Tbc1d2 TBC1 domain family, member 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TBC1D2 mRNA CTD PMID:32553695 NCBI chr 5:62,213,001...62,261,467
Ensembl chr 5:62,212,982...62,260,105
JBrowse link
G Tbc1d5 TBC1 domain family, member 5 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TBC1D5 mRNA CTD PMID:32553695 NCBI chr 9:1,144,641...1,747,732
Ensembl chr 9:1,145,700...1,746,397
JBrowse link
G Tbxas1 thromboxane A synthase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TBXAS1 mRNA CTD PMID:32553695 NCBI chr 4:66,624,181...66,846,745
Ensembl chr 4:66,670,618...66,846,805
JBrowse link
G Tenm4 teneurin transmembrane protein 4 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TENM4 mRNA CTD PMID:21785161 NCBI chr 1:161,183,858...161,885,094
Ensembl chr 1:161,401,527...161,880,923
JBrowse link
G Tesc tescalcin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TESC mRNA CTD PMID:19480007 NCBI chr12:44,141,258...44,174,701
Ensembl chr12:44,141,422...44,174,583
JBrowse link
G Tfrc transferrin receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TFRC protein CTD PMID:20025956 NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
JBrowse link
G Thbs2 thrombospondin 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of THBS2 mRNA CTD PMID:19480007 NCBI chr 1:56,653,929...56,683,571
Ensembl chr 1:56,653,938...56,683,731
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 decreases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TIMP1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of TIMP1 protein
CTD PMID:12097258, PMID:31332895 NCBI chr  X:1,364,771...1,369,451
Ensembl chr  X:1,364,786...1,369,384
JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TIPARP mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA
CTD PMID:32553695 NCBI chr 2:157,316,293...157,342,979
Ensembl chr 2:157,316,266...157,341,469
JBrowse link
G Tkt transketolase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TKT mRNA CTD PMID:12376462 NCBI chr16:6,609,670...6,634,608
Ensembl chr16:6,609,668...6,634,595
JBrowse link
G Tle4 TLE family member 4, transcriptional corepressor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TLE4 mRNA CTD PMID:12376462 NCBI chr 1:231,394,606...231,531,396
Ensembl chr 1:231,393,379...231,530,786
JBrowse link
G Tln2 talin 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TLN2 mRNA CTD PMID:32553695 NCBI chr 8:73,009,980...73,441,536
Ensembl chr 8:73,014,137...73,194,837
JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TMEFF2 mRNA CTD PMID:32553695 NCBI chr 9:55,379,130...55,673,704
Ensembl chr 9:55,384,100...55,673,829
JBrowse link
G Tmem132c transmembrane protein 132C decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TMEM132C mRNA CTD PMID:19480007 NCBI chr12:32,806,372...33,130,746
Ensembl chr12:32,808,022...33,016,885
JBrowse link
G Tmem37 transmembrane protein 37 increases methylation
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of TMEM37 promoter
[9,10-Dimethyl-1,2-benzanthracene results in increased methylation of TMEM37 promoter] which results in decreased expression of TMEM37 mRNA
CTD PMID:21489049 NCBI chr13:36,094,665...36,101,443
Ensembl chr13:36,094,520...36,101,411
JBrowse link
G Tmpo thymopoietin multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TMPO protein CTD PMID:22248470 NCBI chr 7:31,847,412...31,872,416
Ensembl chr 7:31,847,410...31,872,423
JBrowse link
G Tmprss6 transmembrane serine protease 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TMPRSS6 mRNA CTD PMID:19480007 NCBI chr 7:119,659,323...119,689,953
Ensembl chr 7:119,659,324...119,689,938
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF protein; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of TNF mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein]
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein
CTD PMID:20043298, PMID:24995432, PMID:27891153, PMID:31926054, PMID:32662567 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tnfaip3 TNF alpha induced protein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TNFAIP3 mRNA CTD PMID:32553695 NCBI chr 1:14,401,103...14,416,369
Ensembl chr 1:14,402,913...14,412,807
JBrowse link
G Tnfrsf14 TNF receptor superfamily member 14 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNFRSF14 mRNA CTD PMID:21527772 NCBI chr 5:172,328,259...172,337,221
Ensembl chr 5:172,328,262...172,335,892
JBrowse link
G Tnfsf9 TNF superfamily member 9 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNFSF9 mRNA CTD PMID:21527772 NCBI chr 9:9,909,942...9,912,276
Ensembl chr 9:9,909,948...9,912,276
JBrowse link
G Tnmd tenomodulin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TNMD mRNA CTD PMID:32553695 NCBI chr  X:104,684,676...104,700,173
Ensembl chr  X:104,684,676...104,700,173
JBrowse link
G Tp53 tumor protein p53 multiple interactions
decreases expression
increases expression
increases activity
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; [epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]; Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]; resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA]
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TP53 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TRP53 protein modified form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein
9,10-Dimethyl-1,2-benzanthracene results in increased activity of TP53 protein
2,4,3',5'-tetramethoxystilbene inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; [[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]; [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA; [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]
CTD PMID:12734332, PMID:18791811, PMID:20043298, PMID:20655369, PMID:22009531, PMID:23717041, PMID:24269759, PMID:25478867, PMID:30101532, PMID:32553695 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Tp53inp1 tumor protein p53 inducible nuclear protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TRP53INP1 mRNA CTD PMID:32553695 NCBI chr 5:24,402,895...24,419,651
Ensembl chr 5:24,410,863...24,416,888
JBrowse link
G Tpm3 tropomyosin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TPM3 mRNA CTD PMID:12376462 NCBI chr 2:189,423,534...189,451,340
Ensembl chr 2:189,423,559...189,451,029
JBrowse link
G Tppp3 tubulin polymerization-promoting protein family member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TPPP3 mRNA CTD PMID:19480007 NCBI chr19:37,424,323...37,428,075
Ensembl chr19:37,424,324...37,427,989
JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TRIB3 mRNA CTD PMID:32553695 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRPC6 mRNA CTD PMID:19480007 NCBI chr 8:6,811,543...6,917,534
Ensembl chr 8:6,811,543...6,917,535
JBrowse link
G Tslp thymic stromal lymphopoietin increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP
AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP]
CTD PMID:27869817 NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
JBrowse link
G Tspan8 tetraspanin 8 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TSPAN8 mRNA CTD PMID:21785161 NCBI chr 7:58,814,805...58,847,564
Ensembl chr 7:58,814,805...58,847,563
JBrowse link
G Tspo translocator protein multiple interactions EXP 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [PK 11195 binds to TSPO protein] CTD PMID:21037200 NCBI chr 7:124,460,358...124,470,610
Ensembl chr 7:124,460,358...124,470,609
JBrowse link
G Ttc27 tetratricopeptide repeat domain 27 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of TTC27 mRNA CTD PMID:21785161 NCBI chr 6:21,735,833...21,880,008
Ensembl chr 6:21,735,834...21,880,003
JBrowse link
G Tuba4a tubulin, alpha 4A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TUBA4A mRNA CTD PMID:21527772 NCBI chr 9:82,415,599...82,419,918
Ensembl chr 9:82,415,605...82,419,288
JBrowse link
G Tubb2b tubulin, beta 2B class IIb increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TUBB2B mRNA CTD PMID:12376462 NCBI chr17:31,441,640...31,444,687
Ensembl chr17:31,441,630...31,482,759
JBrowse link
G Tubb4b tubulin, beta 4B class IVb multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TUBB4B protein CTD PMID:22248470 NCBI chr 3:2,441,585...2,444,369
Ensembl chr 3:2,441,733...2,444,281
JBrowse link
G Twist1 twist family bHLH transcription factor 1 multiple interactions
increases expression
ISO mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TWIST1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of TWIST1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of TWIST1 protein
CTD PMID:29663660 NCBI chr 6:53,401,241...53,403,235
Ensembl chr 6:53,401,109...53,403,214
JBrowse link
G Txnip thioredoxin interacting protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TXNIP mRNA CTD PMID:32553695 NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
JBrowse link
G Tyr tyrosinase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of TYR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of TYR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of TYR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of TYR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of TYR protein CTD PMID:20691676 NCBI chr 1:151,012,598...151,106,802
Ensembl chr 1:151,012,598...151,106,802
JBrowse link
G Tyrobp transmembrane immune signaling adaptor Tyrobp decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TYROBP mRNA CTD PMID:32553695 NCBI chr 1:88,875,370...88,879,305
Ensembl chr 1:88,875,375...88,879,303
JBrowse link
G Ubd ubiquitin D increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of UBD mRNA CTD PMID:19480007 NCBI chr20:1,876,175...1,878,126
Ensembl chr20:1,876,173...1,897,814
JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of UBE2C mRNA CTD PMID:32553695 NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159
JBrowse link
G Ube2g1 ubiquitin-conjugating enzyme E2G 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of UBE2G1 mRNA CTD PMID:21785161 NCBI chr10:59,173,268...59,254,458
Ensembl chr10:59,173,268...59,254,453
JBrowse link
G Ust uronyl-2-sulfotransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of UST mRNA CTD PMID:32553695 NCBI chr 1:2,330,631...2,627,654
Ensembl chr 1:2,333,778...2,627,747
JBrowse link
G Vapb VAMP associated protein B and C affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of VAPB mRNA CTD PMID:21785161 NCBI chr 3:171,832,558...171,871,042
Ensembl chr 3:171,832,500...171,868,647
JBrowse link
G Vcp valosin-containing protein multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of VCP protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of VCP protein
CTD PMID:22248470 NCBI chr 5:58,426,548...58,445,953
Ensembl chr 5:58,426,549...58,445,953
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of VEGFA protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of VEGFA protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of VEGFA mRNA
CTD PMID:19480007, PMID:19502547, PMID:31332895 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
JBrowse link
G Vim vimentin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VIM mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VIM protein CTD PMID:29663660 NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
JBrowse link
G Vldlr very low density lipoprotein receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of VLDLR mRNA CTD PMID:32553695 NCBI chr 1:245,236,819...245,273,688
Ensembl chr 1:245,237,736...245,269,205
JBrowse link
G Vps13b vacuolar protein sorting 13 homolog B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of VPS13B mRNA CTD PMID:32553695 NCBI chr 7:74,118,834...74,722,341 JBrowse link
G Vsnl1 visinin-like 1 multiple interactions ISO VSNL1 protein results in decreased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:20419170 NCBI chr 6:37,001,360...37,121,969
Ensembl chr 6:37,001,356...37,122,023
JBrowse link
G Vti1a vesicle transport through interaction with t-SNAREs 1A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of VTI1A mRNA CTD PMID:32553695 NCBI chr 1:276,310,072...276,508,635
Ensembl chr 1:276,309,927...276,490,602
JBrowse link
G Vwf von Willebrand factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of VWF mRNA CTD PMID:19480007 NCBI chr 4:158,085,059...158,219,525
Ensembl chr 4:158,088,505...158,219,523
JBrowse link
G Wdr1 WD repeat domain 1 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of WDR1 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of WDR1 protein
CTD PMID:22248470 NCBI chr14:76,990,014...77,023,739
Ensembl chr14:76,989,919...77,023,726
JBrowse link
G Xdh xanthine dehydrogenase decreases expression
increases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XDH mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of XDH mRNA
CTD PMID:12376462, PMID:32553695 NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
JBrowse link
G Xpa XPA, DNA damage recognition and repair factor affects response to substance ISO XPA protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:10755388 NCBI chr 5:61,749,767...61,793,641
Ensembl chr 5:61,749,767...61,792,928
JBrowse link
G Xrcc1 X-ray repair cross complementing 1 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of XRCC1 mRNA]
CTD PMID:23717041 NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
JBrowse link
G Xrcc3 X-ray repair cross complementing 3 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in